Normal and cancer stem cells: discovery, diagnosis and therapy international scientific conference. R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv October 5–6, 2017 by unknown
234 Experimental Oncology 39, 234–256, 2017 (September)
NORMAL AND CANCER STEM CELLS: 
DISCOVERY, DIAGNOSIS AND THERAPY 
INTERNATIONAL SCIENTIFIC CONFERENCE
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, 
National Academy of Sciences of Ukraine, Kyiv
October 5–6, 2017
ABSTRACTS
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We recently demonstrated the existence of an adult 
dermal stem cell (DSC) that functions to populate both 
mesenchymal compartments within the hair follicle 
(HF): the inductive cells within the dermal papilla (DP) 
and the connective tissue sheath (CTS) which wraps 
around the distal follicle (Rahmani et al., 2014). Depletion 
of DSCs disrupts normal HF regeneration highlighting 
their potential importance for restoration or prevention 
of hair loss (alopecia). The loss of adult HF is considered 
permanent but in 2007, it was shown that when the skin 
excisions on the back skin of mice are larger than 1 cm2, 
de novo HFs form in the middle of the wound bed after 
re-epithelialization. This wound-induced HF neogenesis 
(WIHN) parallels the development of HFs during em-
bryogenesis. It has been demonstrated that the nascent 
HFs arise from epidermal cells outside the HFs and not 
from the bulge stem cells within the pre-existing HFs. 
However, the origin of the mesenchymal compartments 
of these neogenic HFs is still unclear. We hypothesize 
that the dermal cells in the neogenic HFs originate 
from aSMAve+ cell populations within the dermis. To test 
that, we made full-thickness excisions (> 1 cm2) in the 
dorsal skin of αSMACreERT2ROSAYFP mice. The wounds 
were harvested from 18 days post-wounding (dpw) 
up to 140 dpw to assess the dermal cells in the neogenic 
HFs. Our data reveal that YFP+ve DSCs integrate into ~90% 
of the mesenchymal compartments of the nascent HFs. 
The neogenic HFs successfully complete their hair cycle 
and YFP+ve DSCs appear to have re-assumed their role 
as DSCs within newly formed HFs.
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Introduction. Development of chronic myeloid leu-
kemia (CML) is the result of reciprocal translocation be-
tween chromosomes 9 and 22 that leads to emergence 
of Philadelphia chromosome. Role of BCR domains 
in differentiation of leukemia stem cell remains unclear. 
Investigation of protein-protein interactions can be one 
of the effective ways to reveal those molecular events 
that alter normal cellular processes and cause malignant 
transformation. Previous research showed that USP1, 
cortactin and Hsp27 may interact with PH domain. 
The main function of USP1 protein is to deubiquitinate 
proteins in the cell. Intracellular Hsp27 plays an anti-
apoptotic role and acts as a chaperone protecting in-
correctly formed proteins from aggregation. The main 
function of cortactin is remodeling of actin cytoskeleton 
during fission of clathrin-coated vesicles.
Aim. To design genetic constructs for mammalian 
expression and determination of protein-protein inter-
actions between PH domain of BCR and target proteins 
suitable for the analysis of important signaling pathways 
involved in CML pathogenesis.
Materials and Methods. The standard molecular 
cloning techniques and expression in E. coli strain Ro-
setta.
Results and discussion. Following PCR, we am-
plified target gene sequences USP1, CTTN, Hsp27. 
Their sizes of 2,300 bp, 1,600 bp and 650 bp are in ac-
cordance with expected. Using the ligation reaction, 
we produced pBluescriptSKII (+)-USP1, pBluescriptSKII 
(+)-CTTN and рET42a-hsp27 genetic constructs. 
By subcloning the CTTN gene from pBluescriptSKII 
(+)-CTTN plasmid, we derived pFastFT-N1-CTTN, 
pMediumFT-N1-CTTN, pSlowFT-N1-CTTN. Recom-
binant genetic constructs were successfully identified 
by restriction analysis. The absence of mutations and 
correct reading frame was confirmed by sequenc-
ing. We also produced a genetic construct рET42a-
hsp27 for expression of HSP27 in bacterial host system 
and obtained effective bacterial expression of Hsp27. 
Analysis of protein expression by polyacrylamide gel 
electrophoresis confirmed that the expressed protein 
corresponds to the expected size of about 55 kDa. The 
purified recombinant HSP27 may be used to determine 
presence or absence of interaction with PH domain 
of BCR by far-Western.
Conclusions. All DNA constructs obtained can 
be effectively used to study biological role of interactions 
of PH domain of BCR with USP1, cortactin and Hsp27 for 
better understanding of molecular mechanisms of CML 
pathogenesis. The development of the genetic con-
structs with inserts corresponding to the coding se-
quences of CTTN, USP1 and PH domain of BCR that may 
be useful for determining spatio-temporal resolution 
of target protein inside the cell on subdiffraction level 
is under way.
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THE CONTENT OF TUMOR STEM CELLS IN BRAIN 
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Introduction. At the present stage of research the 
possible relationship of cancer stem cells (CSCs) and the 
development of various tumors including brain tumors are 
actively studied. CSCs are responsible for metastasis, infil-
trative growth, recurrence of gliomas as well as resistance 
to chemotherapy and radiotherapy. While the question 
of relationship between content of CSCs and malignancy 
of gliomas is controversial, it is known that a fundamental 
feature of CSCs is their ability to form neurospheres in vitro.
Aim. The purpose of the study was to investigate 
the neurosphere formation of CSCs from brain gliomas 
of varying degrees of malignancy and analyze CD133+ 
content in such cells.
Materials and Methods. 51 biopsies of gliomas with 
varying degrees of malignancy were obtained during neu-
rosurgery. Histological diagnosis of brain tumors was con-
ducted in accordance with International Histological Classifi-
cation of Tumors of the Central Nervous System (2007). The 
cell phenotype cells was analyzed by immunofluorescent 
method using monoclonal antibody to CD133 (a marker 
of CSCs) by cytometry protocol on flow cytometry (Beck-
man Coulter, USA). The CSC ability to form neurospheres 
was studied in vitro in suspension and dissociated cultures.
Results and discussion. It is established that the 
number of CD133+ cells in glioblastomas was 8.92 ± 6.81% 
and in anaplastic astrocytomas 7.98 ± 4.62%. In benign 
gliomas of second degree of anaplasia, the content 
of CD133+ cells was less by half than in malignant gliomas. 
Upon culturing of glioma cells in DMEM in the presence 
of EGF within 10–12 days, fluctuating neurospheres char-
acteristic of CSCs were formed in 86.3% of glioblastoma 
samples, 78.5% anaplastic astrocytomas, 88.2% anaplas-
tic olihodendrogliomas and 66% benign astrocytomas.
Conclusions. The increased content of CD133+ cells 
was detected in malignant gliomas of III and IV degree 
of malignancy with accompanying increased percentage 
of neurosphere formation upon in vitro culturing. Further 
study of these populations of cells may provide a new under-
standing of the nature of tumors and the causes of treatment 
failure in brain gliomas.
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Mesenchymal stem cell (MSC), a non-hemopoietic 
stem cell defined also as “mesenchymal stem/stromal cell” 
or “multipotent stem cell” is one of the major components 
of the connective tissue system. As early as in the beginning 
of 1970s, A. Fridenstein demonstrated that MSC may dif-
ferentiate into myofibroblasts. Nowadays, the role of myo-
fibroblasts in the formation of microenvironment of tumors 
has been well proven. MSCs reside in the bone marrow, 
dental pulp, adipose tissue and several other tissues. These 
cells possess the adhesive properties and do not express 
the markers of the hematopoietic stem cell. MSCs have the 
capacity to differentiate into the osteoblasts, chondrocytes, 
adipocytes, myocytes and neuron-like cells. The wide range 
of the biological features of MSC explains their implication 
in tumor growth. To date, several mechanisms of MSC 
involvement in the stimulation of tumor growth have been 
elucidated: a) MSCs interact with tumor cells increasing 
their metastatic potential and inducing EMT in tumor cells; 
b) MSCs secrete various soluble factors and cytokines in-
cluding those stimulating tumor growth such as IL-6, IL-8, 
IL-10, TGFβ, HGP; c) MSCs are involved in the formation 
of chemoresistance that has been proved for many types 
of tumors; sometimes chemoresistance is provided by in-
creasing expression of MDR, MRP, LRP; and MSC exosomes 
are no less important for chemoresistance. The role of MSCs 
in suppression of the immunological response cannot 
be overemphasized. Such immunosuppressive effects are 
displayed as follows: a) MSCs affect antigen recognition, 
primarily by TGFβ production; b) MSCs interfere with interplay 
between lymphocytes and tumor cells; c) MSCs promote 
the escape of tumor cells from immunological surveillance; 
d) MSCs inhibit cytotoxic potential of cells possessing killer 
activity, in particular via ROS generation; e) MSCs are actively 
involved in the formation of perivascular niches in all types 
of tissues being responsive to various extra- and intracellular 
signals. On the other hand, according to the general principles 
considering the effects of microenvironment on tumor growth 
one should be aware also of the MSC protective effects 
involving several mechanisms: a) MSCs may enhance INF 
gamma production followed by activation of lymphocytes and 
stimulation of tumor growth; b) sometimes MSC vesicles may 
counter-balance the negative effects of MSCs themselves; 
c) MSCs may protect tumors from cytostatics by inhibition 
of caspase activity that holds true in several tumors.
To sum up, MSCs represent the heterogeneous popu-
lation capable of various activities depending on the stage 
of tumor growth, the source of MSCs and seve ral other 
factors. The diversity of the biological effects of these cells 
explains why MSCs may be involved both in stimulation and 
inhibition of tumor growth.
IMPACT OF BONE MARROw STEM CELLS 
AND SOLUBLE FACTORS ON BIOLOGICAL 
PROPERTIES AND EPITHELIAL-MESENCHYMAL 
TRANSITION IN BREAST CANCER CELLS
n.o. Bezdieniezhnykh, o.o. Lykhova, 
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Background. Bone marrow is a tissue containing stem 
cells and cells of various degrees of differentiation.
Aim. To study the crosstalk between breast tumor 
cells with epithelial or mesenchymal phenotype and bone 
marrow stem cells of breast cancer (BC) patients using 
noncontact co-cultivation in vitro system in the pres-
ence of biological or chemical antitumor agents (IFN-α, 
mitomycin C, zoledronic acid), which are epithelial-
mesenchymal transition (EMT) modifiers.
Materials and Methods. Human breast carcinoma cells 
with epithelial phenotype (MCF-7 cell line), mesenchymal 
phenotype (MDA-MB-231 cell line) and aspirates of bone 
marrow (BM) of BC patients with a different clinical course 
of the disease (groups “Stabilization” (BM-S) and “Progres-
sion” (BM-P)) were used in noncontact co-cultivation system 
in vitro. BM stem cells were used as a source of soluble 
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factors of microenvironment for tumor cells ex vivo. Cell 
culture methods, immunoenzyme and immunocytochemical 
analysis have been used.
Results. It was shown that co-cultivation of MCF-7 cells 
with BM-P did not affect the tumor cells growth and migration 
activity and co-cultivation with BM-S stem cells was accom-
panied by significant inhibition of such biological properties 
of tumor cells. At the same time, significant inhibition of the 
same parameters of MDA-MB-231 cells was observed only 
after their cultivation in the presence of BM-P cells.
Co-cultivation of MCF-7 cells with BM-P resulted 
in 30% increase of the E-cadherin expression in BC cells. 
The incorporation of IFN-α in such system leads to changes 
in E-cadherin expression (increase in MCF-7 + BM-S and 
decrease in MCF-7 + BM-P). The cultivation of MCF-7 cells 
in the presence of BM-S resulted in a 2-fold decrease in the 
number of Vimentin+ cells, and the addition of IFN-α or mi-
tomycin C enhanced the effect by inhibiting Vimentin ex-
pression in MCF-7 cells by 50% or 100%, respectively.
It was shown that soluble factors produced by BM stem 
cells practically did not affect the number of E-cadherin+ 
MDA-MB-231cells, whereas the addition of IFN-α to this 
co-culture system or the complex action of BM-S and mi-
tomycin C were accompanied by a statistically significant 
increase in the level of expression of this protein in these 
tumor cells. It was interesting to note, that a significant 
decrease in the number of Vimentin+ MDA-MB-231 cells 
by 50% was observed after their co-cultivation with 
BM stem cells in the presence of zoledronic acid.
The analysis of the soluble factors produced by cells in the 
experiment showed that co-cultivation of MDA-MB-231 cells 
with BM cells did not change significantly the levels of VEGF 
and IL-6 in the culture medium. Only IFN-α in such system 
suppressed VEGF level by 50% compared to control. It was 
shown that co-cultivation of MCF-7 cells with BM cells did not 
affect significantly the VEGF level in the culture medium, but 
the addition of mitomycin C or IFN-α resulted in a decrease 
of VEGF level. The cultivation of MCF-7 cells with BM-S leads 
to two-fold increase in the level of IL-6 in the culture medium, 
and IFN-α in this system intensified the effect and the level 
of IL-6 increased 4-fold compared to control.
It should be noted, that in such co-cultivation system, 
regardless of the tumor cells type, the level of TGF-β1 did 
not change significantly in any setting of the treatment and 
TNF-α was not detected in the culture medium.
Conclusions. The significant changes in biological 
properties of BC cells dependently on their ЕМT status were 
detected after their interaction with BM cells of BC patients 
with a different clinical course of the disease in noncontact 
co-cultivation system. BM cells of BC patients had differ-
ent modifying effect on proliferative and migration activity 
of tumor cells depending on the clinical course. It has been 
shown that cytokines are important elements of tumor 
microenvironment that influence EMT status of tumor cells.
CONTENT OF STEM-LIKE CANCER CELLS 
OF VARIOUS DIFFERENTIATION DEGREE 
AT DIFFERENT STAGES OF BREAST CANCER 
(EXPERIMENTAL STUDY)
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Introduction. It is known that the manifestation 
of malignant tumors including breast cancer (BC) is stipu-
lated by the presence of cancer stem cells (CSCs). In this 
regard, the vital is the question of studying the content and 
functional activity of CSCs in BC development. The ap-
propriate experimental model for the evaluation of these 
indices is the C3H mice with high incidence of mammary 
cancer.
Aim of research was to assess the proliferative potential 
of CSCs varying in differentiation degree in BC develop-
ment in the mammary tissue itself, mammary cancer and 
metastases in lung.
Materials and Methods. Experiments were per-
formed in 16-month-old female CBA and C3H mice, 
weighing 18–20 g, kept under standard vivarium condi-
tions of the IPC&C of the NAS of Ukraine. The mice were 
divided into 5 groups of 10 animals each: Group 1 — intact 
CBA mice (control); Group 2 — C3H mice without tumors; 
Group 3 — C3H mice with tumors (0.5–1.0 cm in diam-
eter); 4 — C3H mice with tumors (1.5–2.0 cm in diam-
eter); 5 — those with tumors (2.0 cm in diameter) and 
lung metastases (0.5 cm in diameter). Content of CSCs 
in tissue suspensions (mammary tissue, tumors and 
metastases in lungs) was determined by flow cytometry 
(FACS Calibur) using monoclonal antibodies (BD, USA) 
to CD24, CD44 molecules.
Results and discussion. In tissue of murine mam-
mary gland of group 2, CD44hi cells were detected, which 
were absent in the mammary gland of CBA mice. The 
average content of CD44+/24- cells in mammary gland 
in mice of group 2 exceeded the same index in intact 
animals. The concentration of CD44+/24+, CD44-/24+ cells 
was lower (p < 0.05) than in the control group. In Group 
3 of animals with minimal tumor size, the content of CD44hi 
cells in mammary gland was unchanged if compared with 
group 2, while their number in tumor was twice decreased.
Thus, the content of CSCs (CD44hi) in tumors of the 
group 3 mice was lower than in mammary gland, while 
a number of more differentiated CD44-/24+ cells on the 
contrary was higher than in the control group. The dif-
ference between the content of CD44hi, CD44+/24-, 
CD44+/24+ was statistically significant in mammary 
gland and tumors in mice of group 4. On the background 
of increasing content of CD44hi, a significant difference 
between the number of CD44-/24+ in mammary gland 
and tumor was kept. At the same time, in mammary gland 
the number of CD44+/24- cells increased and the number 
of CD44+/24+ and CD44-/24+ cells decreased, in tumors, 
in contrast, a decrease in CD44+/24- subpopulations 
and an increase in CD44+/24+ and CD44-/24+ cells were 
observed.
It should be noted that in mice of group 5 in mam-
mary gland the concentration of CD44hi, CD44+/24- cells 
decreased and CD44+/24+ cells increased, while the 
number of CD44-/24+ was unchanged. In mammary tu-
mors of this group the number of CD44+/24-, CD44+/24+ 
and CD44-/24+ cells increased significantly and ex-
ceeded the corresponding values for group 4. However, 
the number of CD44+/24- cells in metastases did not 
change, and the content of CD44-/24+ and CD44+/24+ 
cells decreased. At the same time, the number of CD44hi 
cells significantly increased relative to the tumor values 
in this group.
Conclusions. It has been found that in C3H mice, 
the redistribution of subpopulation composition was ob-
served in mammary gland as far as the tumor was mani-
fested. The results emphasize the importance of CSCs 
in BC pathogenesis.
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Introduction. Metastatic spread of tumor cells is the 
main cause of cancer-related deaths. Chemokines are the 
most important factors controlling cellular migration. Stem 
cell receptor CXCR4 as a transmembrane chemokine re-
ceptor and its specific ligand CXCL12 (stromal cell-derived 
factor 1, SDF-1α) play a vital role in dissemination of tumor 
cells from primary sites, transendothelial migration as well 
as homing of cancer stem cells. In the tumor microenviron-
ment under hypoxic condition there is possible mechanism 
by which cells of a growing tumor are reprogrammed to ex-
press the CXCR4 receptor thereby enhancing the metastatic 
potential of the tumor cells. Therefore in the current work 
it was investigated how hypoxia in primary tumor of patients 
with gastric cancer (GC) affects the CXCR4 expression.
Aim of research. The aim was to find the association 
between CXCR4 expression in GC and bone marrow (BM) 
cells with tumor hypoxia, disseminated tumor cells (DTC) 
and clinical outcome.
Patients. All patients with primary GC were diagnosed 
and treated at the City Clinical Oncological Center (Kyiv). 
No patient received chemotherapy or radiation prior to sur-
gery. Histological types of tumor were evaluated by WHO 
histological classification (2000). Tumors were classified and 
staged according to the 2002 version of the UICC staging 
system. All patients were thoroughly informed about the study 
that was approved by the local ethics committee.
Methods. DTCs and CXCR4 expression were detected 
using immunocytochemistry in BM cytospin preparations, 
CXCR4 expression in tumor — using immunohistochemistry, 
tumor hypoxia level was evaluated by 31NMR spectroscopy. 
The statistical analyses were conducted.
Results. Overall, 78.5% of patients had tumors with 
CXCR4+ cells. The direct correlation between CXCR4+ cells 
and the level of hypoxia in primary tumor was shown (r = 
0.492; р < 0.05); the probability of the appearance of high 
number of CXCR4+ cells in tumor increased by a factor 
of 5 (OR = 4.926, 95% CI 7.027–23.628, p = 0.046), when 
tumors were characterized by severe and moderate hy-
poxia. Moreover, under such hypoxic condition appearance 
of tumor cells in BM increased by a factor of 11.4 (OR 11.4, 
95% CI 2.71–47.89, χ2 =12.3, p < 0.001). CXCR4+ cells 
in tumor tissue were detected in 80% of the patients with 
the DTC in BM. When tumors were characterized by positiv-
ity for CXCR4 cells, the probability of appearance of DTCs 
in BM of patients increased by a factor of 4.0 (OR = 4.024, 
95% CI 1.0597–15.2782, χ2 = 4.367, p = 0.0408) and the 
relative risk of DTCs appearance was approximately 2.0 (RR 
= 1.955, 95% CI 0.999–3.824, p = 0.05). The CXCR+ cells 
in BM were observed in 62.1% of patients with CXCR4+ 
tumors. Risk of unfavorable outcome in all patients with 
CXCR4+ tumors increased almost by a factor of 3.0 (HR = 
2.82; 95% CI 1.162–6.832; p < 0.05). It was evaluated that 
in patients both with M0 category and CXCR4+ BM, the risk 
of unfavorable outcome increased by a factor of 3.4 (HR = 
3.4; 95% CI 1.156–12.054; р < 0.03). Overall survival (OS) 
was significantly longer in all patients with tumors character-
ized by CXCR4-negative status as compared to the patients 
with CXCR4+ tumors (log-rank test, p = 0.0375), and in the 
patients with M0 (log-rank test p = 0.0137). OS was longer 
in all patients with BM characterized by CXCR4-negative 
status as compared to the patients with CXCR4+ BM (log-rank 
test, p = 0.0441).
Conclusion. Obtained results have clearly shown that 
overexpression of homing-protein CXCR4+ in tumor, espe-
cially in the patients with M0 category, mediated by the level 
of hypoxia in primary tumor, is associated with presence 
of CXCR4+ cells as well appearance of DTC in BM and cor-
related with poor survival and unfavorable clinical outcome. 
CXCR4+ BM is a risk factor of unfavorable prognosis for the 
patients with GC especially in the patients with M0 category.
THE EFFECTS OF SUPEROXIDE RADICALS 
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The balance between self-renewal and differentiation 
is a critical function of stem cells (SC) during the develop-
ment of the organism and maintaining tissue homeostasis 
throughout the life. Recent studies of SC in the resting 
phase show that their redox state is regulated by superoxide 
radicals (SORs) and nitric oxide (NO).
The main sources of SORs in the SC are the mitochon-
drial respiratory chain. It should be pointed out that SORs 
and NO are integral components of the redox-state of the 
cell and because of related functions, they affect each 
other. Low levels of these molecules in the SC maintain 
resting state and self-renewal. Increased levels of SC gen-
eration cause proliferation/differentiation, senescence, 
apoptosis, or depletion. Thus, generation of SORs and 
NO in the SC must be strictly regulated for carrying out 
function of redox homeostasis support and repairing dam-
aged tissues. Generation of SORs and NO in the SC is regu-
lated by numerous internal and external factors, and their 
deregulation leads to the development of pathological 
conditions. The consequence of aberrant generation 
of SORs in SC tumor is the initiation and progression of ma-
lignancy. So, today the urgent problem is the development 
of redox homeostasis regulators in the SC, although the 
mechanisms and signal pathways regulated by the SORs 
and NO have been not yet studied clearly. NO can cause 
nitrosylation of SH-groups in FeS-proteins and release 
of Fe ions from mitochondria Fe-S centers and other Fe-
containing proteins, which lead to the impairment of their 
functions. In physiological concentrations, NO modulates 
the electron transport in the mitochondrial respiratory chain 
depending on the concentration of intracellular oxygen, 
redox-state of the electron transport chain (ETL) and 
the level of cellular hypoxia. SORs and NO have different 
chemical properties, different reactivity, time of half-life, 
which determines the rate of their interaction with DNA and 
other structural molecules in the cell. It is believed that stem 
cell are located in niches, which are characterized by hy-
poxia and low levels of SORs and NO, and it is crucial for 
maintaining the self-renewal potential in the SC. But, while 
SC are being isolated for therapeutic or research purposes, 
generation of SORs is enhanced and extracellular matrix 
undergoes degradation. SORs and NO can alter gene ex-
pression and activity of key metabolic regulators, thereby 
to determine the specific metabolic patterns of the cells. 
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Rising levels of SORs and NO cause oxidative damage 
to DNA, proteins, lipids, carbohydrates, premature aging 
and apoptosis. The accumulation of oxidation-induced 
DNA damage in human cord blood SC leads to the loss 
of its ability to restore hematopoiesis. NO inhibits SC pro-
liferation through blocking the cell cycle and induces 
CD34 apoptosis. Decreased activity of NOS increases the 
number of SC in the bone marrow and improves hemato-
poiesis. Selective reactivity of SORs and NO to biotargets 
is the basis of the impact on specific signaling pathways 
that are initiated or damaged by them. These reactions 
cause allosteric or configurational changes in the target 
protein, which alter their function and interaction with other 
proteins, causing a variety of signaling events.
Thus, the safe use of SC in the clinic requires improve-
ment of the production technology with strict control 
of SORs, NO, matrix metalloproteinases levels that will 
promote their ability to self-renewal, proliferation and 
differentiation.
CHARACTERIZATION OF CELLS ISOLATED 
FROM A BREAST CANCER BEFORE AND AFTER 
NEOADjUVANT CHEMOTHERAPY
I. Cakstina, v. Pirsko, M. nakazawa-Miklasevica, 
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Introduction. Breast tumors contain heteroge-
neous cell populations. There can be dormant cancer 
cells among them that can survive therapy and give rise 
to secondary tumors. Therefore, in-depth studies are 
necessary for better understanding of the tumor patho-
genesis. In this study, a standardized cell isolation and 
characterization methods were used to look at cell growth 
and differentiation state at different time points (before 
and after neoadjuvant therapy).
Aim. To isolate, characterize and compare cells isolated 
from the same breast cancer tumor biopsies before and after 
neoadjuvant chemotherapy. The main tasks were: (i) to iso-
late and culture cells from breast cancer biopsies before and 
after neoadjuvant chemotherapy; (ii) to perform cell growth 
and morphological analysis; (iii) to analyze expression 
of breast cancer type related genes; (iv) to compare gene 
expression profiles among various isolated cell fractions 
before and after neoadjuvant chemotherapy.
Materials and Methods. Cells were isolated from core 
biopsies by sequential enzymatic disaggregation collecting 
cell fractions obtained after each disintegration step and 
culturing them in four diverse cell growth media until the 
fourth or fifth passage (the length of cultivation depended 
on the numbers of cells) for further analysis and biobank-
ing. Cells were monitored in phase contrast microscope 
and fed every two to three days. Several gene expression 
panels were developed to characterize isolated cell cul-
tures: proliferation panel, tumor inducing cell marker panel, 
epithelial-mesenchymal transition marker panel, epithelial 
differentiation gene panel with subpanels for common dif-
ferentiation, basal and Her2++, basal cell regulator, luminal 
cell, luminal progenitor and mature luminal cell regulators.
Results and discussion. All isolated cultures had 
lower proliferation rate in comparison to reference fibro-
blasts (shown by growth data analysis and gene expres-
sion profile). Also, gene expression profile is different 
in cells cultured in media supplemented with 10% FBS 
from other three media that had 5% FBS and supplemen-
tal growth factors/hormones.
Patient in this study was diagnosed as luminal type 
breast cancer. The results from analysis of differentiation 
gene expression may suggest that obtained cell popula-
tions contain both luminal and basal cells. Elevated ma-
ture luminal cell regulatory gene expression may suggest 
that isolated populations contain cells with active epithe-
lial differentiation program allowing them to differentiate 
towards more luminal cell type.
The analysis of the cultures isolated after chemotherapy 
is still ongoing and preliminary results will be presented 
in the conference.
Conclusions. In this study, we isolated different cell 
populations from the breast cancer core biopsies before 
and after neoadjuvant chemotherapy. Isolated cells show 
some degree of heterogeneity and gradual decrease in the 
proliferation potential by each passage. Cell pools probably 
contain both basal and luminal mammary cells capable 
of differentiating towards more mature luminal state.
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Despite the intensive implementation of the confor-
mal strategy in the practice of radiation oncology, cells 
of normal tissues inevitably fall in the tumor irradiation 
zone. These are microscopic tumor infiltrates in normal 
tissues; tissue structures located at the inlet and outlet 
of the therapeutic ionizing radiation (IR) beam; blood ves-
sels and, correspondingly, cells of the circulating blood 
pool, exposed to radiation at the same dose as the tumor. 
In the process of therapeutic irradiation of cancer patients, 
the early negative effects are most common in the he-
matopoietic system. Their severity depends both on the 
absorbed dose of IR and on the volume of irradiated red 
bone marrow. The mechanisms of these effects are due 
not only to the high radiosensitivity of the hematopoietic 
stem cells, but also to the individual radiosensitivity of the 
organism as a whole.
Earlier, in Ukraine, experience in bone marrow trans-
plantation has been already accumulated (L.P. Kindzelsky 
et al., 1987, 1992, 1996, 2001) in the patients with acute 
radiation sickness of II–III degree who took part in the 
emergency operations after Chernobyl accident (April–May 
1986). The purpose of this medical intervention consisted 
in a temporary replacement of the “failure” in the hemato-
poiesis using the donor bone marrow so that during this 
period the own pluripotent hematopoietic elements could 
start the production of blood elements. The period of pas-
sage through the stages of differentiation is 12–15 days 
for the elements of the myeloid and erythroid series. Al-
logeneic bone marrow was implanted 3–6 weeks after 
irradiation, that is, after detoxification procedures and the 
decay of short-lived radionuclides. First, during this time, 
the remaining elements in the bone marrow continued the 
production of blood cells; secondly, incorporated radio-
nuclides could destroy not only own, but also transplanted 
myelocaryocytes. We have observed no early and late 
complications in any of the victims after the bone marrow 
transplantation.
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At the present time, in order to minimize the radiation 
damage to healthy tissues, stem cells are used after in-
tensive antitumor therapy. This method includes grafting 
bone marrow (a mixture of hematopoietic and mesenchy-
mal stem cells), mesenchymal stem cells, the mobilization 
of autologous stem cells by growth factors (A.G. Konoply-
anikow et al., 2007; J.M. Lombaert et al., 2008). Stem cell 
transplantation is carried out in an oncological clinic with 
the aim of replacing damaged and dead cells in the patients 
with radiation-induced damage to the tissues of vital organs. 
It should be noted that most of the experimental and pre-
clinical studies in this direction were carried out with a single 
irradiation. Therefore, their results must be extrapolated 
with great care to the conditions of fractionated irradiation, 
when the factors of the formation of radioresistance, the 
processes of repopulation, etc. are involved.
EPIGENETIC AND METABOLIC REPROGRAMMING 
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Radiotherapy is a standard curative treatment for solid 
cancers including head and neck squamous cell carcinoma 
(HNSCC) and prostate cancer (PrCa). Although HNSCC and 
PrCa might be curable at early stages, advanced diseases 
have a poor prognosis. Tumor relapse after therapy is attrib-
uted to the population of tumor initiating, or cancer stem cells 
(CSCs) which escaped or survived the treatment. It has been 
proposed that CSCs in some types of tumors can be protect-
ed from the different treatment modalities by multiple intrinsic 
and extrinsic mechanisms that, along with CSC plasticity and 
heterogeneity, can be a driving force for tumor recurrence. 
Analysis of the phenotypes and density of CSCs in tumor bi-
opsies prior the treatment and development of CSC-targeted 
therapies might be an essential approach for optimization 
and personalization of the treatment strategies. This lecture 
will review the results of studies of the Group of Biomarkers 
for Individualized Radiotherapy (OncoRay, Dresden) on the 
development of CSC-based predictive biomarkers and ra-
diosensitizers for HNSCC and PrCa.
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Introduction and Aims. Although the histological 
assessment of therapeutic response significantly helps 
to determine prognosis in breast cancer treated with 
neoadjuvant (preoperative) therapy, the problem caused 
by discrepancies in interpretation of results obtained from 
different pathologists remains actual mainly because 
of lack of standardized assessment criteria and methods. 
We propose that DNA content profiling of the affected (can-
cerous) tissue in combination with immunohistochemical 
judgment of its aggressiveness before and after therapy 
may facilitate interpretation of therapeutic response.
Patients and Methods. The study population con-
sisted of 12 breast cancer patients, 11 of those 12 patients 
had locally advanced breast cancer. The patients under-
went diagnostic procedures at the Latvian Oncology Cen-
ter of the Riga East University Hospital in 2014 and 2015. 
The tissue specimens were collected after the patients’ 
informed consent was obtained in accordance with the 
Ethics regulations. Both diagnostic biopsy and opera-
tion material, such as primary tumors surgically removed 
after 3–9 courses of neoadjuvant chemotherapy (NAC) 
using standard doses of paclitaxel and doxorubicin, were 
subjected to DNA content analysis with image cytometry. 
DNA histograms were classified according to Auer et al. 
(1980). Positions of DNA peaks were determined by cal-
culating DNA index (DI) values. Based on the presence 
or absence of aneuploid DNA peaks and cells that poly-
ploidize (> 4.5C), it seems reasonable to expect that NAC 
effects may vary from positive to negative (i.e., opposite). 
Immunohistochemical staining was applied to evaluate 
proliferation (Ki67), invasiveness (CD44), and self-renewal 
factors characteristic for stem cells (SOX2 and NANOG).
Results and discussion. The analysis of DNA content 
profiles in operation material from 12 patients revealed the 
features of tumor non-responsiveness to NAC in 7 cases, 
among which 4 cases showed enhanced polyploidization, 
suggesting the negative NAC effect. Polyploidization is likely 
to be attributed to the cycling of near-triploid cells (DI = 
1.26−1.74). Polyploid cells were positive for Ki67, SOX2, 
NANOG, and CD44. Notably, stress-induced polyploidiza-
tion of tumor cells (including breast cancer cells) expressing 
self-renewal stem cell factors was also demonstrated in vitro 
by several groups of researchers [Salmina et al., 2010; Ghisol-
fi L. et al., 2012; Lagadec C. et al., 2012] prompting us to sup-
pose that the polyploid cells and their descendants released 
by de-polyploidization can possess stem cell characteristics.
Conclusions. DNA content profiling data that may not 
necessarily correlate with histopathologic scoring data 
provide the additional helpful information for interpreting 
therapeutic responses in NAC-treated breast cancers. Since 
in some cases NAC effects may be unfavorable, the use 
of further treatment strategy should be carefully considered. 
Therapy-resistant polyploid tumor cells possessing stem 
cell features can be induced in vivo as well, assuming that 
this process is not autonomous, but rather stipulated by the 
tumor microenvironment and intra-tumor heterogeneity.
This work was supported by European Social Fund 
2013/0023/1DP/1.1.1.2.0/13/APIA/VIAA/037.
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Introduction. Both classical and contemporary 
models of hematopoiesis are based on study of normal 
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stem cells and early progenitor cells (G. Mathe et al., 
I.L. Chertkov, A.I. Vorobiov; J.E. Dick et al.; I.L. Weiss-
man et al.). The new approach based on studying cy-
tochemical, immunophenotypic and molecular-genetic 
features of leukemic blast cells seems to be advanta-
geous for better understanding of the hematopoiesis 
under physiological conditions specifying and clarifying 
the pathways for the development of terminally dif-
ferentiated blood cells of various lineages originating 
from hematopoietic stem cell (HSC) (A.C. Schmidt, 
G.K. Przybylski).
The clones of blast cells in acute myeloid leukemia 
represent the progenies of leukemic stem cells (LSCs). 
The populations of LSCs in most cases mirror normal 
granulocyte-macrophage progenitors (GMPs) and pre-
viously uncharacterized lymphoid-primed multipotential 
progenitors (LMPPs) (N. Goardon et al.).
Aim. The analysis of immunocytochemical features 
of leukemic cells in patients with different types of leu-
kemia studied at the Department of Oncohematology 
proved to be useful to put forward several suggestions 
as to the possible links between progenitor cells in the 
scheme of hematopoietic cell differentiation.
Methods. For immunocytochemical study of leuke-
mic blast cells (APAAP and LSAB-AP methods) we used 
a broad panel of monoclonal antibodies (MoAbs) pro-
posed by WHO experts for classification of acute leuke-
mias that include markers of hematopoietic progenitor 
cells (CD34, HLA-DR, CD45), B-lineage markers (CD19, 
CD20, CD22, CD79a), T-lineage markers (CD2, CD3, 
CD5, CD7), markers of myeloid lineage (CD13, CD33, 
CD15, MPO, CD117) and megakaryoblasts (CD41, 
CD61).
Results and discussion. Our findings suggest that 
leukemic cells in pro-B-ALL and monoblastic leukemia 
(AML M5a) may derive from the common LSC analogous 
to the presumed progenitor for B cells and monocyte/
macrophages in normal human hematopoiesis. We also 
demonstrated the similarities of immunophenotype 
between blast cells in acute erythroid leukemia (AML 
M6b) and megakaryoblastic leukemia (AML M7). Such 
similarity hints to the existence of the common bipo-
tent progenitor cells in AML M6b and AML M7, which 
is analogous to precursor cell common for megakaryo-
cytopoiesis and erythropoiesis.
The important data for understanding the hierarchy 
in normal human hematopoiesis were obtained in study-
ing some types of acute leukemias of ambiguous lineage 
(acute undifferentiated leukemia, mixed phenotypic 
acute leukemias — B/myeloid and T/lymphoid). In some 
cases of acute lymphoblastic leukemia (ALL) from earlier 
B cell progenitors, co-expression of myeloid markers 
(CD13, CD33, CD15) is observed. However, we have 
never seen T cell lineage associated antigens in B-ALL 
leukemic blasts. Also, in ALL of T cell origin we do not 
find out B cell differentiation antigens. Our findings call 
into question the real existence of common lymphoid 
progenitors (CLP) in human hematopoiesis postulated 
elsewhere.
Conclusions. The data on the immunophenotype 
of leukemic blast cells in various forms of leukemia 
may be useful for the analysis of hematopoiesis 
under physiological conditions. Further studies may 
challenge several conventionally accepted differ-
entiation pathways in existing schemes of human 
hematopoiesis.
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Introduction. In patients with brain tumors, changes 
in the content of stem cells in gliomas and cells of periph-
eral blood are noted (neutrophilia, lymphopenia, throm-
bocytosis).
Aim. To compare the ratios of peripheral blood cells: 
platelet to lymphocyte ratio (PLR), platelet to neutrophil ratio 
(PNR), neutrophil to lymphocyte ratio (NLR) with the content 
of stem cells in gliomas of varying degrees of anaplasia.
Methods. The hemogram indices of 105 patients with 
brain tumors and 28 healthy persons were analyzed. The 
blood indices were measured on the automatic hemato-
logical analyzer Mindray 3000 plus, the ratio of PLR, PNR 
and NLR was determined in the peri pheral blood. The 
expression of receptors for CD133 and CD15 in tumor cell 
suspension was studied by flow cytometry on CYTOMICS 
Fc 500 (Beckman Coulter USA) using anti-CD133 and 
CD15-FITC antibodies (Millipore).
Results and discussion. In gliomas of the I–II degree 
of anaplasia, the content of CD133+ cells was 3.3 ± 1.1%, 
in anaplastic gliomas — 5.1 ± 3.2%, in glioblastomas — 
8.1 ± 2.2%. CD15+ cells (embryonic cell receptor) were 
detected in gliomas twice as often as CD133+ for each 
degree of anaplasia. The content of stem cells CD133+ 
CD15+ in gliomas increased with an increase of the degree 
of anaplasia. In this case, the percentage and absolute 
content of lymphocytes in the blood decreased. In malignant 
gliomas, an increase in PLR, NLR was observed in com-
parison with astrocytomas. It has been established that low 
values of PLR and NLR are observed with a relatively higher 
remission in patients with glioblastomas.
Conclusions. In malignant gliomas, the content 
of stem cells in the tumor tissue increases, and in the 
peripheral blood the va lues of cells PLR and NLR reliably 
increases and PNR decreases. Hematological indices 
can be used as prognostic markers of clinical course 
of gliomas and the effectiveness of treatment.
CONTRIBUTION OF EHRLICH CARCINOMA 
SUBPOPULATION COMPOSITION 
IN MAINTAINING TUMOR GROwTH
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Introduction. Development of malignant tumors re-
sults from expansion of cancer stem cells (CSCs) possess-
ing unlimited potential of self-maintenance. There is a need 
in further study of functional and structural characteristics 
of these cells in various types of model systems.
Aim of the work was to identify the subpopulation 
composition of Ehrlich carcinoma cells including those 
with the signs of CSCs as well as their tumorigenicity.
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Materials and Methods. Ehrlich carcinoma cells were 
transplanted intraperitoneally into BALB/c mice. Total 
population of Ehrlich carcinoma cells was divided by mag-
netic separation method with BD IMagnet cell separation 
system (USA) into CD44+- and CD44–-fractions. The growth 
potential of total population of Ehrlich carcinoma cells, 
CD44+- and CD44–-cell fractions was assessed after 7 days 
following transplantation. The volume of ascitic fluid in the 
peritoneal cavity was measured and cell concentration was 
counted. Immune phenotypic analysis of the subpopulation 
composition of tumors was performed using monoclonal 
antibodies to CD4, CD24, CD117, Sca-1 molecules with 
flow cytometer “FACS Calibur” (“BD”, USA).
Results. Phenotypic analysis demonstrated that Eh-
rlich carcinoma is a heterogeneous population of tumor 
cells of various differentiation degree. Identification of the 
Sca-1 structure in virtually all the cells of Ehrlich carcinoma al-
lows us to consider it as a versatile marker of this type of tumor. 
The particular significance of the subpopulation of CD117+ 
cells in maintaining microenvironment for tumor growth was 
demonstrated. Cells with CD44high phenotype, being the part 
of the CD44+ CD24– population may be considered as the 
candidates for CSCs in this model system. This assump-
tion was confirmed by a comparative study of tumorigenic 
potential of the cells from the fractions CD44+ and CD44–. 
It was shown that the CD44+-fraction cells had a much higher 
ability to form a tumor with the predominant content of highly 
potent tumor-inducing CD44high and CD44+CD24– cells. It was 
demonstrated that the cells of CD44+ fractions were able 
to grow even at a 100-fold lower concentration (104 cells/
mouse) used for transplantation as compared to unfraction-
ated Ehrlich carcinoma population (106 cells/mouse). On the 
contrary, tumorigenic potential of CD44– fraction was much 
lower. Upon administration of 106 CD44– cells/mouse, ascite 
developed only in 50% of animals with total cell count in the 
peritoneal cavity being 5 times less compared to transplanta-
tion of unfractionated Ehrlich carcinoma cells.
Conclusion. The subpopulation composition of inocu-
lated tumor cell line of Ehrlich carcinoma was studied and the 
significance of CD44+ subpopulation in maintaining the growth 
of this type of tumor was established. Cells with the CD44high 
phenotype being the part of the population of CD44+CD24– 
could be considered as CSCs in this model system.
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Introduction. Deuterium depleted water (ddw), in its 
physico-chemical characteristics, differs from the water 
of natural isotope composition (V. Goncharuk, 2011). How-
ever, the biological activity of ddw is poorly understood. The 
ddw protective properties are confirmed by toxicological 
studies, from which it follows that ddw, due to its trans-
port properties, effectively removes toxins and metabolic 
products from the body (R. Robins, 2012). Different con-
centrations of deuterium in water can differently affect the 
proliferative activity of the cell culture of prokaryotes and 
eukaryotes in vitro (G. Somlyai, 2010; O. Mosin, 2014). 
Positive effect of ddw in studies with transplantable tumors 
in laboratory animals and in other in vivo and in vitro experi-
ments (H. Wang, 2013) was noted.
Aim. To study the effect of ddw on the functional 
characteristics of cells in vitro.
Materials and Methods. After preparing growth media 
based on ddw and deionized water (miliQ), the final concen-
tration of deuterium in water was D/H = 30 ± 2 ppm and 150 ± 
2 ppm, respectively. Skin biopsies were dissociated by enzy-
matic treatment for 1 h in 0.05% collagenase IA and 0.05% 
pronase. The cells were cultured in DMEM:F12 supplemented 
with 10% FBS, 2 мМ L-glutamine and 1 ng/ml FGF-2 in a multi-
gas incubator at 5% CO2 and 5% O2. The following assays 
were done: clonogenic potential (CFU test) at 2nd and 4th 
passages and counting cell doubling time (CDT) at 2nd, 3rd, 
4th, 5th and 6th passages. Human cancer cell lines A549 (lung 
carcinoma) and HT29 (colon adenocarcinoma) were used. 
The method of scratching was used to study the “amoeboid” 
movement of cancer cells within 12–24 h.
Results and discussion. It was established that 
growth media based on ddw contributes to a significant 
push to the colony formation of human dermal fibroblasts 
in the early passages by 15–20% more than in water of the 
natural D/H ratio. The population doubling times in colonies 
of human dermal fibroblasts, in late passages, are shorter 
by 4–6 h in ddw than in the water of the natural isotope ratio 
D/H. This may indicate a larger reserve of culture dividing 
cycles in a growth medium based on ddw than in the water 
of the natural isotope ratio D/H. A549 and HT29 cancer 
cells filled the monolayer damage zone 50–70% slower 
with the addition of ddw than the water-based control 
of the natural D/H ratio. The data obtained require ad-
ditional studies to determine the molecular mechanisms 
of deuterium action on intracellular structures.
Conclusions. The effect of the isotope ratio of D/H in wa-
ter on the proliferative potential and the rate of colony-
forming units of human dermal fibroblasts in vitro was es-
tablished. It was shown that ddw contributes to a significant 
slowing of the “amoeboid” movement of A549 and HT29 hu-
man cancer cells. However, according to the results of our 
work, the role of deuterium in biological systems in vitro is not 
completely determined, which requires additional studies 
in the field of chemistry, physics and biology of water.
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Introduction. Placenta, amnion and umbilical cord 
are usually discarded after childbirth whereas these 
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tissues may serve as a valuable source of different cell 
types. These postnatal extra-embryonic tissues are read-
ily available and their potential use for cell therapy pos-
ses no ethical issues for either autologous or allogeneic 
application.
Aim. We aimed to isolate and characterize the cell 
types which could be obtained from postnatal extra-
embryonic tissues.
Materials and Methods. Fresh tissues (no more than 
12 h after delivery) were used for enzymatic or explants 
methods of cell isolation. Obtained cultures were further 
maintained at 5% oxygen. At P3 cell phenotype was as-
sessed by FACS and the multilineage differentiation assay 
was performed.
Results and discussion. We have isolated multiple 
cell types from postnatal tissues. Namely, placental mes-
enchymal stromal cells (Pl-MSCs) from placenta chorionic 
disc, chorionic membrane MSCs (ChM-MSCs) from free 
chorionic membrane, umbilical cord MSCs (UC-MSCs) 
from whole umbilical cord, human umbilical vein endothe-
lial cells (HUVECs) from umbilical vein, amniotic epithelial 
cells (AECs) and amniotic MSCs (AMSCs) from amniotic 
membrane. All isolated cell types displayed high prolif-
eration rate together with the typical MSCs phenotype: 
CD73+CD90+CD105+CD146+CD166+CD34-CD45-HLA-DR-. 
HUVECs constitutively expressed key markers CD31 and 
CD309. All MSCs and AECs were capable of osteogenic 
and adipogenic differentiation. The only exceptions were 
the Pl-MSCs and isolated by enzymes UC-MSCs that failed 
typical osteogenic differentiation. Surprisingly, UC-MSCs 
isolated via explants qualitatively demonstrated osteogenic 
differentiation. Thus obtained MSCs cultures fulfill mostly 
all minimal MSCs criteria. Of note, AECs, initially possess-
ing typical epithelial morphology, progressively acquired fi-
broblastoid appearance at P2-P3 probably due to the EMT.
Conclusions. We have shown that a wide variety 
of cell types can be easily isolated from extra-embryonic 
tissues, banked and expanded ex vivo for regenerative 
medicine applications. These cells possess typical MSCs 
properties and can be considered an alternative to adult 
MSCs, obtained from bone marrow or fat, especially for 
allogeneic use.
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Introduction. It is known that breast cancer (BC) 
consists not only of the neoplastic cells but also of the 
changed stroma. The stroma, which is associated with 
metastases, includes the proteins of extracellular matrix 
and the cellular components, in particular mesenchymal 
stem cells (MSCs), the blood vessels and the immune 
cells. The various studies have shown conflicting data 
on the MSC role in the development of BC. Such con-
tradictions may depend on a wide range of the factors, 
including differences in the setting of experiments, the 
heterogeneity of MSC populations, the dose and the time 
of injection of these cells, and also on the model. The study 
of the influence of the humoral factors from MSCs on the 
development of BC is very relevant in recent years. In ad-
dition, it is important to study the change in the epithelial 
phenotype to the mesenchymal phenotype in the tumor 
cells. EMT cells actively proliferate and self-renew, which 
leads to an increase in the number of the heterogeneous 
populations. It has been shown that the most adequate 
model of the study of tumor population in vitro is a multi-
layer (3D) cell culture. The target effect on the expression 
of the molecules that regulate EMT is promising for cancer 
therapy, including BC.
Aim of the study was to compare the expression of the 
major EMT markers in the tumor cells of breast adenocar-
cinoma (MCF-7 cell line) under the influence of c-medium 
from MSCs in 2D and 3D cell cultures.
Materials and Methods. MCF-7 cell line (breast 
adenocarcinoma) was chosen as an experimental model 
in vitro. The monolayer cell culture was cultured in standard 
conditions (37 °C, 5% CO2, humidity 95%). The initial density 
of culture was 2×104 cells/cm2. To initiate the generation 
of the spheroids, the monolayer cell culture was removed 
off the substrate after four days of the incubation, using 
0.25% Trypsin-EDTA, and placed in the nutrient medium 
with 5% carboxymethyl cellulose, 5×105 cells/ml. Then the 
plates were incubated on an orbital shaker at 50 rpm for 
3–5 h. Human BM-MSCs were cultured with MCF-7 cells 
and multicellular tumor spheroids by non-contact method. 
Detection of the markers (EpCAM, vim, CKs) in 2D and 
3D cell culture was performed using IHC method with the 
primary monoclonal antibodies.
Results and discussion. Our results demonstrate the 
differences in the expression of the epithelial-mesenchymal 
transition markers in 2D and 3D breast cancer cell cultures. 
Thus, the percentage of epithelial markers (cytokeratines 
and epithelial cell adhesion molecule) in the tumor spheroids 
is less than in the cells of monolayer, however, the spheroids 
cells begin expressing a mesenchymal marker — vimentin. 
C-medium from hBM-MSCs reduces the volume of the 
spheroids by 61% compared with the control and promotes 
an increase in the expression of the tumor-associated mark-
ers — cytokeratins and EpCAM in 2D and 3D cell cultures, 
but only in 3D culture the vimentin expression increased.
ADAPTOR PROTEIN RUK/CIN85 ENHANCES 
THE FEATURES OF CSCS IN BREAST CANCER CELLS
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Introduction. Cancer stem cells (CSCs) are known 
as a population of tumor cells with high tumorigenic poten-
tial and self-renewal ability. These cells are characterized 
by a number of properties, such as expression of specific 
molecular markers, higher invasiveness and metastatic po-
tential, drug resistance, expression of “embryonic” genes. 
Adaptor proteins play significant role in assembly of signal-
ing complexes mediating various cellular processes includ-
ing acquiring for the development of stem-like phenotype. 
In this study we investigated the effect of adaptor protein 
Ruk/CIN85 on the CSSs properties of breast cancer cells.
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Materials and Methods. As a model we used two breast 
cancer cell lines: weakly-invasive human MCF-7 cell line and 
highly-invasive mouse 4T1 cell line. In order to analyze the role 
of Ruk/CIN85 in the manifestation of CSCs features, we gen-
erated stable sublines with overexpression of Ruk/CIN85 and 
with its downregulation. Proliferation rate was estimated 
by MTT-assay and growth curves. Invasive ability was ana-
lyzed using Boyden chamber assay. Adhesion-independent 
growth ability was estimated by mammospheres formation 
assay. Gene expression was evaluated by RT-qPCR.
Results. In 2D cell culture, the transition of both hu-
man and mouse Ruk/CIN85 overexpressing breast cancer 
cells from epithelial to rounded and mesenchymal phe-
notype was observed. It was also demonstrated that Ruk/
CIN85 negatively regulates MCF-7 and 4T1 cell prolifera-
tion and adhesion while substantially enhances invasive-
ness of Ruk/CIN85-overexpressing cells. It turned out that 
in both cases cells with overexpression of Ruk/CIN85 pro-
duce more mammospheres than control ones. Analysis 
of stemness related genes expression demonstrated that 
in MCF-7 cells with Ruk/CIN85 overexpression NANOG, 
ID-1, Oct4, KLF-4, and CCL-2 genes were up-regulated, 
while in 4T1 cells Ruk/CIN85 overexpression resulted 
in up-regulation of NANOG, KLF-4, SNAIL1, Lcn2 and 
down-regulation of Myb genes.
Conclusion. The obtained data suggest that adap-
tor protein Ruk/CIN85 is a key regulatory factor involved 
in the development of stemness features in breast cancer 
cells.
This study was partially supported by SC STCU and 
SCOPES grants.
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Introduction. A set of mesenchymal stem cells from 
oral tissues were described in the last decade. Detailed 
characterization and comparison of the ECM and adhe-
sion profile of different mesenchymal stem cell cultures 
has not yet been performed.
Aim of this research is to isolate primary mesenchymal 
cell cultures from adult (DPSC) and deciduous tooth pulp 
(SHED), periodontal ligament (PDL), dental apical papilla 
(SCAP), bone marrow (BMC) and gingiva (GMSC) and 
to characterize them for expression of specific extracellular 
matrix and adhesion molecules using RT Real time PCR.
Materials and Methods. DPSC, SHED, PDL, SCAP, 
BMC, GMSC were isolated from unadulterated dental, al-
veolar bone and gingival explants from patients undergoing 
routine surgical operations in Oral and Maxillofacial Sur-
gery Clinic of Dental Faculty, Medical University — Sofia, 
Bulgaria, after acquiring informed consent. Explants were 
digested in 3 mg/ml Collagenase I/ Dispase and seeded 
in culture flasks with DMEM complemented with 20% FBS 
and antibiotics. Cells were passaged after reaching 70% 
confluence. Cells up to the 3rd passage were used for the 
experiments. Total RNA was extracted with RNeasy Plus 
Mini kit, cDNA was synthesized with RT2 First Strand Kit and 
analyzed with RT2 Prolifer PRC Array, Human Extracellular 
Matrix & Adhesion Molecules Array (all QIAGEN, German-
town, MD, USA) following manufacturer‘s instructions.
Results and discussion. Analysis of adhesion and 
ECM markers showed significant differences between dif-
ferent oral mesenchymal stem cell cultures. Comparison 
of collagen isotypes expression showed also significant 
differences in fibrillar collagen expression and particularly 
Collagen I, with highest expression in BMC and lowest 
in SCAP.
Analysis of integrins showed similarity for the most 
abandoned β subunit is ITGB1 followed by ITGB5. 
ITGB3 on other hand were mostly expressed by dental 
mesenchymal stem cells.
Significant differences in expression of integrin α sub-
units were discovered. ITGA8 was the most abundant except 
in PDL and BMC where ITGAV and ITGA5 prevailed respec-
tively. Stem cell related ITGA1 and ITGA6 were expressed 
in DPSC, RDL and SCAP and ITGA6 expression was much 
lower than ITGA1 in other three sell types.
Comparison of matrix-metalloproteinases (MMP) 
showed the highest amounts of MMP2 and MMP14 in all 
cells with significant difference in other minor expressed 
types.
Cluster analysis of total examined gene expression re-
vealed similar expression profiles of SCAP and PDL cells, 
differing significantly from BMC and GMSC, whereas 
DPSC and SHED showed bigger similarities with BMC 
and GMSC respectfully.
All these results suppose the differences in potential 
for wound healing, cell migration, modulation of the im-
mune response and participation in carcinogenesis of the 
mesenchymal stem cell subpopulations.
Conclusions. Oral tissues contain a set of different 
mesenchymal stem cells, having different adhesion and 
ECM profile, thus possessing different stem cell proper-
ties. Further analysis and comparison between mesen-
chymal stem cell population gene expression is needed 
for better understanding of stem cell potential of these 
adult stem cells. This understanding would refine the 
knowledge about adult stem cells and their role in healthy 
and pathologic conditions and may lead to development 
of regenerative and cell therapy methods.
CYTOCHEMICAL AND IMMUNOPHENOTYPICAL 
FEATURES OF CELLS IN BLAST CRISIS 
OF CHRONIC MYELOID LEUKEMIA
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Introduction. Multistage process of hematopoiesis 
is sustained by hematopoietic stem cells (HSCs) and pro-
genitor cells that are generated in embryonic development. 
Being at the base of the whole hematopoietic hierarchy, 
HSCs finally give rise to all blood lineages in the adult or-
ganism. The study of the upper hierarchy of hematopoietic 
system is in fact the topical problem. The molecular biology 
techniques, genetic engineering, and flow cytometry are 
widely used nowadays with the aim of elucidating the origin 
of specified hematopoietic lineages. The study of mor-
phocytochemical and immunocytochemical features 
of leukemic blast cells of various origin and differentiation 
levels originating by transformation of the correspond-
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ing progenitor cells may be also useful as one of the 
approaches to clarify some challenging aspects relating 
to normal hematopoiesis.
Aim. To define linear origin and differentiation level of leu-
kemic cells in various forms of blast crisis of chronic myeloid 
leukemia (CML BC).
Methods. Cytomorphological, immunohistochemical, 
cytochemical, statistical.
Results and discussion. When CML BC of monocytic 
type was compared to acute monoblastic leukemia origi-
nating de novo, no differences could be observed in cy-
tomorpholgy and cytochemical features of leukemic cells. 
Nevertheless, immunophenotyping revealed expression 
of CD19, CD36, and CD61 in CML BC contrary to de novo 
acute monoblastic leukemia (AML M5). Furthermore, the 
expression of CD7 and CD56 in CML BC was much more 
intensive as compared to de novo AML M5.
Despite the common morphological features of blasts 
in megakaryocytic CML BC and de novo acute megakario-
blastic leukemia (AML M7), some differences were evident 
upon their cytochemical study. Namely, in CML BC activity 
of acid phosphatase was manifested as the granules against 
the background of the diffusely stained cytoplasm whereas 
in de novo AML M7 cytochemical features of blast cells varied. 
In cases of less differentiated cells in AML M7, the cytochemi-
cal reactivity of blast cells was rather inert (except for acid 
phosphatase) similar to that in blasts of CML BC. In more 
mature blasts in AML M7, some other enzymes were detected 
by the cytochemical techniques (except for myeloperoxidase). 
Analysis of immunophenotype revealed several stages of blast 
differentiation in de novo AML M7. On the contrary, phenotype 
of blast cells in CML BC was monomorphic in all patients. More-
over, contrary to CML BC, blast cells in AML M7 expressed 
CD7 and CD36. When cytomorphological, cytochemical 
and immunophenotypical features were compared in cells 
of de novo acute myeloid leukemia with minimal signs of dif-
ferentiation and CML BC with minimal signs of differentiation, 
no distinctions were evident.
Conclusion. The origin of different types of BC CML 
indicates to the secondary leukemic transformation that 
occurs at the level of multipotent progenitor cells, whereas 
in de novo acute myeloid leukemia transformed leukemic 
cells seem to originate from oligolineage hematopoietic 
progenitor cells.
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Introduction. Umbilical cord blood hematopoietic stem 
cells (UCB-HSCs) are in the category of the most studied 
adult multipotent stem cells (M.S. Santos, P. Ventura-Junca, 
2012). As a component of the already formed human body, 
which is in the neonatal period of its own development, UCB-
HSCs have the property of replicating themselves, maintain 
their differentiation potential and, consequently, are capable 
of hematopoietic tissue regeneration (D.L. DiGiusto, 1996; 
Q.L. Hao et al., 2001). In general, the study and use of adult 
stem cells does not raise such serious ethical issues related 
to the source of extraction, which are painful for human em-
bryonic stem cells. At the same time, a number of common 
problems associated with all stem cells are actual for the 
UCB-HSCs, in particular, issues related to clinical research 
in this field. There are also the specific nature issues that are 
inherent in this type of human stem cells.
Aim. To discuss specific and common ethical aspects 
of research, banking and clinical applications of UCB-
HSCs.
Methods of research. Systemic causal-dialectical 
analysis of practical research experience, world-wide 
scientific literature data, international legal standards 
and recommendations.
Results and discussion. Cord blood as an effective 
alternative source of hematopoietic tissue is recognized due 
to a number of important advantages over other unrelated 
allogeneic hematopoietic stem cell transplants (E. Gluckman, 
2009; A.R. Smith, J.E. Wagner, 2009). These benefits include: 
lack of donor risks, availability of frozen samples, reduced 
incidence of graft versus host and relapse with similar overall 
survival (J. Munoz et al., 2014). Current research on the devel-
opment of methods for improving engraftment, restoring the 
recipient immune system is accompanied by ethical issues 
that are common to transplantology and regenerative medi-
cine: the inadmissibility of commercialization of the human 
body, the balance between the desire for clinical progress 
and scientific caution (С. Petrini, 2012; N. King, J. Perrin, 
2014). The functioning of the two main options of umbilical 
cord blood banks (public and private) raises specific ethical 
and legal issues of control and equitable access to medi-
cal care (N.M. Fisk et al., 2005; N.M. Fisk, R. Atun, 2008; 
C. Petrini, 2010; E. Gluckman, 2012; C. Parco et al., 2013; 
G.M. Guilcher et al., 2015). Provided the absolute benefits 
of altruistic cord blood donation in public banks for the sake 
of public interest over autologous private storage, there are 
problems for priority resolution, such as the need for clear 
regulation of property rights, as well as the wording of the 
rules for granting consent to the definition of the concept 
of a donor, consideration of interests of the newborn and his 
family, confidential safekeeping of medical and social infor-
mation data, development of information forms for the donor 
family, which are connected with the prospects of material use 
(E.A. Meyer et al., 2005; A. Mohr et al., 2012; C. Patrini, 2013; 
R. Isasi et al., 2013; C.L. Stewart et al., 2013).
Conclusion. Considering the prospect of the UCB-
HSC scope expanding, the designated complex of ethical 
issues requires regular monitoring and attention.
EFFECT OF CRYOPRESERVATION FACTORS 
ON BIOLOGICAL PROPERTIES OF UMBILICAL 
CORD BLOOD STEM CELL TRANSPLANT
T.o. Kalynychenko1, M.Yu. Anoshyna1,  
A.I. Gordienko1, e.v. Shorop1, Zh.M. Minchenko , 
v.v. Balan2
1SI “Institute of Hematology and Transfusiology, National 
Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
2SI “National Research Center for Radiation  
Medicine of the National Academy of Medical Sciences 
of Ukraine”, Kyiv, Ukraine
kalynychenko_tetiana@ukr.net
Introduction. Umbilical cord blood (UCB) is widely used 
as a source of stem cells for hematopoietic reconstitution 
(J.E. Wagner, E. Gluckman, 2010; J.N. Barcer, J. Kurtzberg, 
K. Ballen et al., 2017). The limit of cell content and the forced 
use of cryopreservation technologies cause profound study 
of opportunities for saving and expanding the tissue trans-
plantation potential (P.R. Motta et al., 2014; G. Chen et al., 
2015; J. Kieman, P. Damien et al., 2016). It is known that the 
cryoprotection effectiveness consists in controlling the ice 
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formation, the dehydration development and the solution 
effect with the help of cryoprotective substances, directly 
proportional to their concentration (H.T. Meryman, 1971; 
G.M. Fahy et al, 1984; M.J. Taylor et al., 2004; P. Mazur, 1977, 
1984, 2004; J.O. Karlsson, M. Toner, 1996; M.S. Berrada, 
G.S. Bischof, 2001; L.E. Ehrlich et al., 2015).
The effectiveness of umbilical cord hematopoietic tissue 
cryopreservation under the protection of dimethyl sulfoxide 
(DMSO) has been proved by numerous studies (R. Syme 
et al., 2003; D. Bauwens et al., 2005; A.S. Chen-Plotkin 
et al., 2007; A.M. Junior et al., 2007; A. Abdelkefi et al., 2009; 
A. Michael et al., 2012). Therefore, maintaining a balance 
between preservation of biological structures and reduction 
of the potential threat from using of cryoprotective agents 
is considered one of the biggest problems in the cryopreser-
vation of hematopoietic stem cell transplants (HSCT).
Aim. To investigate the changes in the biological prop-
erties of the UCB HSCT during cryopreservation in order 
to determine the ways of their correction.
Materials and Methods. The isolated mononuclear 
fraction was frozen under protection of 5 and 10% 
DMSO. The evaluation of the cell state was carried out 
by morphological, functional, biochemical (determina-
tion of the activity of lipid peroxidation processes (LPP) 
of neutral lipids and phospholipids) methods. The study 
of apoptotic stages was carried out by double annexin V 
(Ann V) and propidium iodide (Pi) staining.
Results and discussion. After exposure with DMSO 
(5% concentration) Ann V+/Pi+ — cell content and cells with 
damaged membranes increased to 2.2 ± 0.3% (p < 0.001) 
and to 1.1 ± 0.5% (p < 0.02), respectively. The exposition 
with higher concentrations of DMSO — 10% caused the 
increasing early stages of apoptosis to 16.1 ± 1.8% (p < 
0.05). Provided that the cryoprotective concentration was 
decreased, there was a reduction in the granulocyte-mac-
rophage progenitor cell (CFU-GM) number (p < 0.001) and 
a decrease of cell viability (from 92.9 ± 0.8% to 85.9 ± 1.0%; 
p < 0.01) in defrosted samples. The correlation of the LPP 
activity with the apoptosis indices and the functional activity 
of the CFU-GM number was identified.
Conclusion. The enhanced activation of the lipid 
peroxidation in the UCB HSCT both indirectly through the 
induction of apoptosis and as a result of the toxic effects 
of the peroxidation products on the cell membranes leads 
to a reduced quality of transplant material. The need for 
correction of these changes should be considered at the 
development of long-term storage technologies.
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Introduction. Inorganic arsenic is a common environ-
mental contaminant and known human carcinogen. Liver 
is the main organ for iron storage and metabolism and 
an important target for arsenic carcinogenesis. However, the 
impact of arsenic on hepatic iron homeostasis is not clear.
Aim of this study was to investigate the effect of inorgan-
ic arsenic on iron metabolism in human liver HepaRG cells.
Materials and Methods. Gene expression in the human 
HepaRG cell line was analyzed by whole genome microar-
ray and quantitative reverse transcription-PCR techniques. 
Protein level of transferrin (TF) was determined by Western 
blot analysis, and iron content was measured by inductively 
coupled plasma mass spectrometry.
Results and discussion. The results showed that 
treatment of human liver HepaRG cells with 1 µM of inor-
ganic arsenic (as NaAsO2) for 14 days increased the ex-
pression of iron metabolism-related genes, TFRC, FTL, 
FTH1 and SLC40A1, while the level of TF mRNA and TF pro-
tein was decreased. Additionally, exposure of HepaRG cells 
to arsenic resulted in an increase of cellular iron content. 
These changes were accompanied by a decrease in a num-
ber of mature functional hepatocytes and expansion of liver 
cancer stem cells, evidenced by the accumulation of pro-
genitor like cells (e.g., primitive biliary cells).
Conclusion. Our results demonstrate that chronic expo-
sure of human liver HepaRG cells to a low dose of inorganic 
arsenic resulted in substantial iron metabolism alterations, 
loss of functional hepatocytes, and activation of liver cancer 
stem-like cells. These findings indicate that arsenic-induced 
iron metabolism dysregulation may be one of the underlying 
mechanisms of arsenic-related liver carcinogenesis.
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PATIENTS TREATED wITH MYELOABLATIVE 
THERAPY AND PERIPHERAL BLOOD STEM CELL 
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Introduction. Intensification of consolidation therapy 
with autologous stem-cell rescue after myeloablative 
doses of chemotherapy could contribute to the improved 
survival of children with high-risk neuroblastoma. How-
ever, long-term cure rates remain low, presumably be-
cause of the emergence of resistant clones or persistence 
of minimal residual disease.
Aim. To investigate the 5-year overall survival of pa-
tients with high-risk neuroblastoma treated with myeloab-
lative therapy and peripheral-blood stem-cell rescue 
(PBSCR) in the National Cancer Institute of Ukraine.
Methods. In 2007–2016, 143 patients with neuroblas-
toma (74 standard-risk (SR) patients and 69 high-risk (HR) 
patients) received treatment in the Scientific and Research 
Department of Pediatric Oncology at the National Cancer 
Institute. The risk group of patients was determined on the 
basis of the most common prognostic factors including 
the child’s age, stage, genetic markers (N-MYC oncogene 
amplification, DNA diploidy). All enrolled patients received 
treatment according to NB-2004 and HR-NBL-1/ESIOP 
protocols. During the late stage of treatment, 54 high-risk 
patients were cured with high-dose chemotherapy (HDHT) 
with autologous stem cell support; of these, 13 patients were 
cured with tandem HDHT.
Results. The 5-year overall survival (OS) was 67% for 
SR patients and 30.4% for HR patients. Depending on the 
child’s age: the OS was 58.8% for patients under 1 year 
of age, while the OS was 19.2% for patients aged 1 year 
or over. We also analyzed the survival rate of high-risk 
patients based on whether the patient has N-MYC gene 
amplification. The OS was 49.8% for N-MYC negative 
subjects and 24.3% for N-MYC positive subjects. Currently, 
the OS is 69.2% for high-risk patients who were treated with 
tandem HDHT with autologous stem cell support.
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Conclusion. The obtained results show that the sur-
vival in high-risk patients aged 1 year or over positive for 
N-myc oncogene was worse greatly than in patients with 
normal N-MYC status. The results of treatment of HR pa-
tients who received tandem HDHT with autologous steam 
cell support are encouraging.
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Introduction. Human skeleton is completely remod-
eled by mesenchymal stem cells (MSC) within roughly four-
and-half years. Bone morphogenetic proteins (BMP) are 
main inducers of bone formation and maintenance apart 
of their crucial roles in morphogenesis of other tissues and 
organs. Optimal activity of BMPs in bone usually requires 
coordinate signals with the Wnt pathway. Consequently, 
several bone diseases occur when BMP or Wnt pathways 
are misregulated. Therefore, proper optimization of the 
osteogenesis requires efficient gene delivery tools on the 
way of modulation of osteoblast differentiation of MSC. Un-
fortunately, classical transfection with multiple transfec-
tion reagents triggers massive cell death in transduced 
MSC. On the other hand, viral tools for gene delivery allow 
to get 100% of efficiently transduced stem cells without 
any detection of toxicity.
Materials and Methods. Human MSC cell were 
isolated from bone marrow aspirates obtained under 
patients’ consent from surgical material upon hip joint 
arthroplasty or from fat using a liposuction. Adv5-based 
vectors were used for efficient overexpression of re-
combinant genes into the mesenchymal precursor cells 
and lentiviral vectors were used for small hairpin RNA 
(shRNA)-mediated knockdown of gene expression.
Results and discussion. The set of adenoviral and 
lentiviral vectors generated at our lab allows to overex-
press or correspondingly downregulate expression of dif-
ferent genes important in regulation of osteogenesis. Us-
age of the gene delivery tools generated at our lab allowed 
us to describe a molecular mechanism that mediates 
osteogenesis regulation by secreted phosphoprotein 2.
Conclusions. Modern viral gene delivery tools open 
a wide window for biomedical studies aiming to investigate 
the molecular mechanisms of human MSC differentiation 
and to optimize the efficacy of regenerative skeletal tissues 
engineering based on MSC incorporation into the grafts.
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Introduction. We obtained a new human stem cell 
line from peripheral blood cells of adult healthy donor. 
It successfully overcame the Hayflick limit and is stable 
(immortalized) cell line. During morphological analyses 
of stained cells at different passages we observed two 
types of cells: epithelioid and fibroblast-like.
Aim. Presence of two morphological cell classes 
is an interesting phenomenon, thus the aim of research 
was to study epithelial-mesenchymal transition (EMT) 
in 4BL cell line.
Materials and Methods. Cells were cultivat-
ed in DMEM with 10% FBS, 100 U/ml penicillin and 
100 µg/ml streptomycin. For morphological studies cells 
were stained with 1% neutral red. The immunophenotype 
was analyzed by flow cytometry on BD FACS Aria (BD, 
USA). Soft agar test was performed in 0.3% agar on Petri 
dish. For array CGH analyses DNA from the cells was ex-
tracted with QIAamp DNA Blood Mini Kit and purified with 
QIAquick PCR Purification Kit (Qiagen, UK). 1 µg of cell 
DNA was hybridized on CytoSure Aneuploidy array slide 
followed by the analysis by the Innopsys Innoscan 710 de-
vice with OGT CytoSure Interpret Software 3.3.2 due to the 
recommendations of the Oxford Gene Technology.
Results and discussion. Maintenance of two mor-
phological cell types: epithelioid and fibroblast-like, first 
of all is concerned with stem cell plasticity and EMT. Stem 
potential of 4BL cell line was revealed in the previous stud-
ies by demonstrating adipogenic, osteogenic and myo-
genic differentiation using special induction mediums.
Presence of different cell types in cell population can 
provide advantages of survival in changing culture condi-
tions. Thus, in soft agar test 4BL cells grew well, proliferated 
without attachment to the substrate and formed colonies. 
It is worth mentioning that ability to grow in semi-liquid 
medium is characteristic both of mesenchymal stem cells 
and cancer cells. We detected the expression of MSC 
markers: CD73+ and CD105+ with flow cytometry. Usually 
EMT is associated with acquisition of malignant state, but 
we have not revealed the expression of Oct4, the marker 
of embryonic stem cell, which is re-expressed in cancer 
stem cells. By array CGH data we have detected partial 
deletion of 12p11.1pter, where Nanog gene is located, 
which is also secondarily activated in cancer cells.
Due to array CGH we have revealed the dupli-
cations of chromosomes with genes, which take 
part in dif ferentiation in bone t issue — FRZB 
(2 q31.1–q33.1) and FGFR3 (4p16.1-pter); in myo-
genic tissue — M-cad herin (16q22.1qter) and NODAL, 
MYOZ1 myozenin 1 (10q22.1q22.2); stem cell potential 
maintenance — MATK, KLF1, GDF15, BST2 bone marrow 
stromal cell antigen 2 (19 р13.3–р12), and also PARD6A, 
which plays role in asymmetric cell division and EMT 
(16q22.1qter).
Conclusions. Population of the stem cell line 4BL 
maintains two morphological cell types: epithelioid and 
fibroblast-like, which is concerned with stem cell plas-
ticity. It is verified by cell differentiation into three types 
of lineages and by easy adaptation of cells to microenvi-
ronment change such as growth in soft agar.
AGE-RELATED CHANGES OF BIOLOGICAL 
PROPERTIES IN THE MULTIPOTENT 
MESENCHYMAL STROMAL BONE MARROw 
CELLS, FUNCTIONING OF THYMUS AND PINEAL 
GLAND IN MICE OF DIFFERENT STRAINS
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Introduction. The bone marrow multipotent mesenchy-
mal stromal cells (BM-MSCs) can differentiate into various 
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directions, produce trophic and immunomodulatory effects, 
influence the differentiation of hematopoietic stem cells. 
With age, the BM-MSCs properties undergo changes, while 
the occurrence of malignancies rises (Gross, 2007; Anisi-
mov et al., 2015). Thymic hormone thymuline influences the 
proliferative capacity of BM-MSCs (Labunets et al., 2012). 
The thymus function is under influence of pineal gland and 
its main hormone, melatonin, possesses geroprotective 
and antitumor properties. In aging, bone marrow-immune-
endocrine interrelations may be linked with genotypes.
Aim. Comparative analysis of the biological properties 
of BM-MSCs, functions of the thymus and pineal gland 
in FVB/N and CBA/Ca mice, varying significantly in their 
life duration, frequency of malignancies (leukemia/lym-
phomas) and general adaptability.
Materials and Methods. The studies were conducted 
on adult (4–6 months) and old (20–22 months) mice. 
FVB/N versus CBA/Ca mice are characterized by both, high 
frequency of spontaneous bone marrow chromosomal 
aberrations and leukemia/lymphomas in aging. These 
mice are sensitive to the B strain of Friend leukemia virus 
and reveal low immune response. In our study, the number 
of bone marrow co lony-forming unit fibroblasts (CFU-Fs) 
was measured by the bone marrow monolayer culture 
technique. The number of granulocyte/macrophage colo-
ny-forming cells (GM-CFCs) in the semi-agar cultures was 
assessed. The phenotyping of BM-MSCs was performed 
using the monoclonal antibodies to mouse membrane 
antigens labeled with fluorochromes. To determine the im-
munomodulatory properties of BM-MSCs, we performed 
a joint cultivation of MSCs from mice of different age with 
syngeneic splenocytes of young mice stimulated by T-cell 
mitogen phytohemagglutinin. The melatonin and thymuline 
levels were determined in the serum.
Results and discussion. The stromal progenitor cells 
significantly increase in their number only in bone marrow 
of old FVB/N mice, indicating age-associated elevated 
ability of the BM-MSCs to proliferation. The number of GM-
CFCs also increased in old FVB mice. On the contrary, 
changes of indices in the old CBA/Ca mice are slight. The 
immunosuppressive effect of BM-MSCs from adult mice 
on lymphocyte proliferation was higher than in old mice. The 
blood thymuline level falls significantly in old CBA/Ca mice 
and remains unchanged in FVB mice. The melatonin level 
decreases more intensely in old FVB/N versus CBA/Ca mice.
Conclusions. The genetic differences in biological 
parameters of BM-MSCs may be linked with particulari-
ties of interrelations between pineal gland and thymus 
functions in aging mice (a), may contribute to the de-
velopment of certain type spontaneous tumors in old 
organism (b).
STEM CANCER CELLS. A NEw CHALLENGE 
IN STUDYING ONCOGENESIS
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The last 20 years due to the great success in the study 
of the biology of human stem cells, a new direction in on-
cology has been defined — the study of the nature of stem 
tumor cells. The theory of stem cells is not recognized 
by all, although there are indisputable facts proving their 
existence, in particular, with glioblastomas.
Thanks to the discovery of cancer stem cells (CSC), 
not only the theory of carcinogenesis has changed, but 
also the concepts of infiltrated growth, the resistance 
to adjuvant methods of treatment acquired new out-
lines. Such properties of CSC as angiogenic potential, 
heterogeneity, differentiated mimicry, migratory and 
tumor-inducing abilities have been proved experimentally. 
CSC are ten times more potent in experimental induction 
of tumors in mice than non-CSC tumor cells. It has been 
established that CSC of different types of human tumors 
have certain phenotypic markers, which allows using 
them for diagnosis and prognosis.
At the same time, there are many challenging questions 
related to CSC. There are no clear phenotypic markers for 
tumor and non-tumor stem cells. Theoretical assumptions 
about the possibility of anti-CSC therapy of carcinogenesis 
have not yet been confirmed. Anti bodies against marker CSC 
molecules (anti CD133+) can both stimulate and suppress 
tumor growth in the experiment. Induction of tumor growth 
in mouse experiments with tumor cells without phenotypic 
signs of CSC (CD133- cells) casts doubt on the assumption 
that CSCs are the only or basic cells capable of inducing 
tumor growth.
Therefore, today the questions about the role of can-
cer-inducing cells in oncogenesis as well as the possibility 
of controlling carcinogenesis with the help of CSC remain 
unresolved.
CONTENT OF CANCER STEM CELLS IN GLIAL 
BRAIN TUMORS
n.I. Lisyanyi, d.n. Stanetskaya, v.M. Semenova, 
T.A. Malysheva, A.n. Lisyanyi, A.I. Potapova
SI “A.P. Romodanov Neurosurgery Institute, National 
Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
Nimun.neuro@gmail.com
Introduction. In recent years special attention has 
been paid to the study of the role of cancer stem cells 
(CSCs) in the pathogenesis of malignant growth. CSCs are 
responsible for migratory ability, radio- and chemoresis-
tance, for induction of new tumors in the experiment, which 
is important for determining the characteristics of tumors 
and predicting the outcome of the disease. The available 
data on the CSC content in brain tumors are contradictory.
Aim. To study the content of CSCs in brain tumors 
of various histology.
Materials and Methods. 134 samples of biopsy 
material of brain tumors were examined with the aid 
of immunohistochemical, immunofluorescence and flow 
cytofluorometry methods. The monoclonal antibodies 
to CD133 (Millipore, USA) CD15 and CD34 (Becton Dis-
kinson, USA) were used.
Results and discussion. CD133+ CSCs have been 
detected in various brain tumors. Their highest content 
was found in glioblastomas and medulloblastomas. After 
repeated surgery, the CSC content in the tumor tissue 
increased. In addition to CD133+ cells, a small number 
of CD34+ and CD15+ cells was also detected. It was found 
that an increase in the content of CD133+ cells in tumor 
tissue is accompanied by a decrease in lymphocyte count 
in the peripheral blood. Even the CSC content in tumors 
of the same histological type (glioblastoma or medul-
loblastoma) varied significantly.
Conclusion. Determination of CSCs in tumor tissue 
can serve as an additional indicator for choosing meth-
ods of combined treatment and predicting the duration 
of remission.
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Introduction. Current state of development of neu-
rooncology is focused on searching the criteria of treat-
ment personalization on the basis of identifying a unique 
set of molecular changes in tumor cells. The neuroepithelial 
stem cell markers are considered among the targets for 
brain glial tumors. CD133 (pro minin-1) molecule may 
be considered as one of the most characteristic biomarkers 
of brain tumor stem cells (BTSC). Cellular and molecular 
similarities between BTSC and normal neurogenic stem/
progenitor cells (NSC/NPC) substantiates the search for 
new methods of treatment of malignant glioma using NSC/
NPC (K.S. Aboody et al., 2013; R.A. Morshed et al., 2015; 
J. Portnow et al., 2016). In particular, immunobiological 
properties of NSC/NPC may be realized via the expres-
sion and production of immunoregulatory cytokines and 
growth factors.
Aim. To study the influence of rat fetal brain neuro-
genic cells conditioned medium (NCCM) on the content 
of CD133+ cells in rat glioma C6 and normal rat fetal brain 
cell cultures.
Materials and Меthods. NCCM was obtained from 
suspensions of neurogenic rat brain cells on the 14th (E14) 
day of gestation. The cells of rat brain glioma (cell line 
C6, n = 6) and cells of rat fetal brain (E14, n = 6) served 
as the material for culturing. The study was performed 
in control cultures (standard cultivation conditions without 
NCCM adding) and research cultures (with adding NCCM 
(0.10 mg/ml) for 48 h). Immunocytochemical staining for 
CD133 molecule was performed using murine monoclo-
nal antibodies to CD133 (Millipore, USA). In cytological 
specimens the changes in cellular composition and the 
number of immunopositive cells were determined and 
morphometric studies were performed.
Results and discussion. According to the immunocy-
tochemical staining, BTSC or CD133+ cells accounted for 
7.2–16.8% of the total number of cells in C6 glioma cultures 
and 25.0–49.7% in fetal rat brain (E14) cultures. CD133+ cells 
were smaller in size than CD13− cells (average values of cell 
sectional area, nucleus cell-sectional area) and had greater 
nuclear-cytoplasmic ratio. CD133+ cells and their nuclei in cell 
cultures of fetal rat brain were twice larger in size than such 
cells in cultures of C6 glioma.
NCCM (0.10 mg/ml for 48 h) reduced 4-fold the 
number of CD133+ cells in C6 rat glioma cell cultures 
(p = 0.02 compared to control, U-Mann — Whitney test). 
Cell cultures of fetal rat brain did not reveal such effect.
The functional role of CD133 in NSC/NPC re-
mains poorly understood. According to J.M. Angelas-
tro and M.W. Lame (2010), exogenous expression 
of CD133 caused a 2–4-fold decrease in apoptosis 
of tumor cells in response to therapeutic agents (doxo-
rubicin, kaptotecin) and CD133+ glioma C6 cells had 
increased by 62% expression of one of ABC-transporters 
(P-glycoprotein), leading to drug resistance, which sup-
port the hypothesis of antiapoptotic CD133 functional 
role in protecting tumor cells, particularly from chemo-
therapeutic agents. Our results demonstrate that NCCM 
reduces the number of CD133-expressing BTSC cells 
in cultured glioma C6 cells but not in cultures of fetal 
rat brain. Moreover, the size of CD133+ cells in cultures 
of glioma C6 and fetal brain differ in size that suggests 
that BTSC of glioma C6 may be qualitatively different 
from NSC/NPC (probably express ligands for the active 
molecular agents of NCCM).
Conclusions. Since CD133 is regarded as critical 
therapeutic target for therapy of brain tumors, the results 
of reducing the number of CD133-expressing cells (BTSC) 
in C6 glioma cell culture under influence of the NCCM can 
be the basis for a comprehensive study of preparations de-
rived from neurogenic fetal cells for the purpose of theoreti-
cal justification of their application in pathogenetic treatment 
of patients with brain gliomas.
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Introduction. The basis of the formation of metastatic 
phenotype of tumor cells is a phenomenon of epithelial-
mesenchymal transition (EMT). The key regulator of this 
process in tumor cells is their microenvironment and, 
in particular, the cellular components of the tumor stroma. 
Mesenchymal stem cells as key elements of the stroma 
are important regulators of tumor progression and its 
sensitivity to antitumor factors.
Aim. To obtain and characterize new stromal cell line 
for studying the interaction between malignantly trans-
formed cells and their microenvironment ex vivo and as-
sessing new approaches to anti-stromal therapy.
Materials and Methods. Cell culture methods, im-
munocytochemical and statistical analysis.
Results. SEBR line of stromal cells from the spontaneous 
breast tumor adenocarcinoma of the rat was established and 
characterized by morphology, growth parameters, immuno-
phenotypical profile and cytogenetic features. SEBR cells 
are characterized by fibroblast-like morphology, a nuclear-
cytoplasmic ratio is similar to normal cells, morphology and 
number of chromosomes was as in normal rat cells (2n = 
42). The cells are characterized by the dominance of mesen-
chymal cell antigens: high expression of N-cadherin (262 ± 
33), Vimentin (280 ± 11), and a low number of cells with pan-
cytokeratin expression. A high level of the expression of stem 
cell marker CD44 (> 200 points by H-Score system) was 
found. The SEBR cells were used in the co-cultivation system 
with malignant transformed rat mammary cells (MRS, MRS-
T5 cell lines) with different morphological characteristics 
and the initial status of EMT associated proteins. The aims 
of investigation were to assess the impact of stromal cellular 
elements on the proliferative and immunophenotypical prop-
erties of tumor cells. In parallel, the effect of normal embryo 
fibroblasts on tumor cells and additional exogenous factors 
with antitumor activity (chemotherapy drugs, cytokines) were 
studied. The conditioned culture medium (CM) was col-
lected and assayed at different phases of cell growth. It has 
been shown that CM from stromal SEBR cells significantly 
stimulates the proliferation of MRS-T5 cells (tumorigenic 
mesenchymal phenotype) and does not stimulate MRS cells 
(nontumorigenic epithelial phenotype). CM from normal 
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fibroblasts does not activate the cellular metabolism of MRS 
and MRS-T5 cells. Moreover, under specific conditions (de-
pending on cell concentration and CM content), a significant 
inhibition of cellular metabolism and proliferation (up to 50%) 
is evident. CM from tumor cells was shown to inhibit SEBR 
cell growth and metabolism (20 to 60%) and stimulate nor-
mal fibroblasts (from 10 to 80%). In the study of sensitivity 
of stromal and tumor cells to drugs, it was found that cells 
are characterized by similar sensitivity to zoledronic acid 
(IC50 1–2 µg/ml), cisplatin (IC50 5–10 µg/ml) and paclitaxel 
(IC50 0.1–0.2 µg/ml). At the same time, the response of these 
cells to the TNF and mitomycin C was different, in particular, 
the tumor cells were more sensitive to mitomycin C and less 
sensitive to TNF (at doses lower than 2000 IU/ml, the stimu-
lation of cellular proliferation was observed) as compared 
to SEBR.
Conclusion. A new cell line SEBR of stromal origin 
with characteristics of stem cells was established and 
characterized. A significant difference between the 
responses of tumor cells with various EMT status on co-
cultivation with SEBR cells was shown.
EFFECT OF PDGF-BB ON PROLIFERATION, 
MATRIX SYNTHESIS AND MINERALIZATION 
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Introduction. PDGF is one of the main active mor-
phogenes in the platelet concentrates which have been 
increasingly used to stimulate tissue healing at the injury 
site. Although in recent years many clinicians apply autolo-
gous platelet derived products to enhance healing process 
and regeneration of PDL, the effect of PDGF on stem cell 
markers expression, enzymatic activity, ECM synthesis 
and mineralization in PDL has not been studied in detail.
Aims. The purpose of the present study is to de-
termine the presence of cells in human PDL capable 
of expressing stem cell and differentiation markers and 
to determine the effect of PDGF-BB on cell proliferation, 
marker expression, collagen synthesis, enzymatic activity 
and mineralization.
Materials and Methods. PDL cells were isolated and 
characterized using stem cell and differentiation markers via 
immunofluorescence and flow cytometry and then cultured 
in vitro and treated with different concentrations of PDGF-
BB. The effect of PDGF-BB on cell proliferation, stem cell 
and differentiation markers expression, soluble collagen 
production, lysyl oxidase (LOX) activity, alkaline phosphatase 
(ALP) activity and calcium nodules formation was assessed.
Results and discussion. PDGF-BB stimulated the 
proliferation of cells with the maximum effect at 50 ng/ml. 
The growth factor increased the expression of stem cell 
markers and SPARC; Col1a2 expression was decreased, 
whereas the expression of Col3a1 and BSPII remained 
unchanged. Soluble collagen production, ALP activity 
and calcium nodules formation were also significantly 
decreased by PDGF-BB; LOX activity was significantly 
increased. Our results show that PDGF-BB initiates 
self-renewal through maintenance of cell proliferation 
and stem cell properties on the one hand, and inhibition 
of abnormal mineralization in human PDL on the other.
Conclusions. PDGF-BB is a powerful promoter of cell 
proliferation that increases the expression of stem cell 
markers; inhibits collagen production and mineralization 
but accelerates the maturation of collagen chains through 
increased LOX activity and SPARC expression.
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S18-2 AND RETINOBLASTOMA PROTEIN 
IN REGULATION OF CELL STEMNESS 
AND DIFFERENTIATION
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e. Kashuba2, 1
1Department of Microbiology, Tumor and Cell Biology 
(MTC), Karolinska Institutet, Stockholm, Sweden
2R.E. Kavetsky Institute of Experimental Pathology, 
Oncology and Radiobiology, National Academy  
of Sciences of Ukraine, Kyiv, Ukraine
elena.kashuba@ki.se
The retinoblastoma (RB) pathway is inactivated 
in several different human cancer forms, including RB, 
osteosarcoma, melanoma, and neuroblastoma. These 
tumors are derived from neural crest from cells that fail 
to undergo terminal differentiation.
We have found that mitochondrial ribosomal protein 
S18-2 can bind RB. Thus, we discovered a novel mecha-
nism of cell fate regulation, which depends on overexpres-
sion of S18-2 (MRPS18-2).
Noteworthy, overexpression of the human S18-2 im-
mortalized primary rat embryonic fibroblasts (REFs) that 
showed properties of embryonic stem cells. Moreover, 
S18-2 is expressed at the high levels in endometrial, 
breast and prostate cancer tissues, as we shown by im-
munohistochemistry and q-PCR.
Moreover, analysis of the available data bases revealed 
the elevated expression of S18-2 at the mRNA levels 
in stem cells and many cancer types. This raises the ques-
tion of whether this protein co-operates with the RB protein 
in differentiation and carcinogenesis. We also hypothesized 
that simultaneous expression of RB and S18-2 proteins 
at the high levels might support stemness.
Here we discuss the mechanisms of how S18-2 pro-
tein, together with RB, is involved in the maintenance 
of cell stemness.
BONE MARROw MESENCHYMAL STEM 
CELLS AND MORPHOFUNCTIONAL STATUS 
OF THE TRANSPLANT
M.e. ospanova1, Z.K. Burkitbayev1, 
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Introduction. In the transplantation immunology, T- 
and B-lymphocytes play an important role in maintaining 
morphoregulatory processes and implementing an im-
munological surveillance to maintain cellular homeosta-
sis. The posttransplant period is affected by the immune 
system imbalance, in particular, of T-cells (CD3), T-helper 
cells (CD4), cytotoxic T cells (CD8), NK cells, plasma cells, 
regulatory lymphocytes (CD4+CD25+FOXP3) and cytokines 
produced by these cells.
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Aim. The aim of the study was to investigate the 
morphofunctional status of the transplant in the post-
transplant period and transplantation of the bone marrow 
derived mesenchymal stem cells (BM-MSC).
Materials and Methods. In the study, two groups 
of mice were involved: a control group (n = 30) with a skin 
graft transplantation and main group (n = 30) with the skin 
graft transplantation combined with BM-MSC. Paraffin 
technique was used for morphological control of transplant 
engraftment after 7, 14, and 21 days. Briefly, the tissue 
was fixed in 10% neutral buffered formalin, and then the 
tissue samples were cut and embedded in paraffin. Tissue 
samples were stained with hematoxylin and eosin. Further 
histological slides were studied by microscopy and photo-
graphed with a digital camera Axiocam color (Germany).
Results and discussion. According to the histologi-
cal analysis and macroscopic observations at day 7, 14, 
and 21 significant differences were seen among the study 
groups. Thus, at day 7, in the control group the state 
of the transplant was unsatisfactory with necrotic graft 
changes and edema occurred. This picture was observed 
almost throughout the study period (at day 7, 14 and 21). 
After fortnight, the transplant of the mice of the control 
group appeared a dark pale in color. A half size of the 
transplant of the control group was rejected, there were 
eruptions of the surgical sutures. Necrosis and edema 
of the graft occurred as well. At the end of the third week, 
there was a complete rejection of the graft in the control 
group. In the main group, during all observation periods 
(at day 7, 14 and 21), the functioning of the transplant 
was noted. It should be noted that after a week of surgi-
cal procedure there were marginal necrosis, edema and 
a pale coloration of the skin. The mice of the main group 
had engraftment of the graft and had no signs of trans-
plant rejection. Under the microscope, moderate edema 
of the graft and lymphohistiocytic infiltration was noted. 
Overall, the function of the graft was retained. At the end 
of observation period, the mice of the main group had the 
complete engraftment and the function of the transplant 
maintained.
Conclusions. The study has allowed establishing 
a connection between transplant engraftment and im-
munoregulatory properties of mesenchymal stem cells, 
both inducers of immunological tolerance, and their 
regenerative properties, which contributed to the full 
engraftment of the graft.
MESENCHYMAL STROMAL CELL-BASED TISSUE 
ENGINEERING
A.Yu. Petrenko, e.Yu. Rogulska, d.n. Tarusin, 
S.P. Mazur, e.B. Revenko, v.v. Mutsenko, 
v.P. Grischuk
Institute for Problems of Cryobiology  
and Cryomedicine, National Academy of Sciences 
of Ukraine, Kharkiv, Ukraine
alexander_petrenko@cryo.org.ua
Introduction. Due to ability to produce a variety of cell 
types multipotent mesenchymal stromal cells (MSCs) 
are promising cellular component for tissue engineering.
Aim. Development of tissue engineered constructs 
on the base of MSCs derived from adult human tissues 
and various 3-D scaffolds.
Materials and Methods. MSCs were isolated from 
adult human bone marrow, dental pulp, adipose and 
dermal tissues after the patient informed consent in ap-
pliance with local Ethical guidelines. MSCs were seeded 
into alginate microbeads (AMB) and wide-porous scaf-
folds prepared on the base of alginate, gelatin, collagen, 
demineralized chitinous skeletons of marine sponges 
and dental osteoplastic composite materials. MSCs vi-
ability, proliferation and capacity to differentiation toward 
adipogenic and osteogenic lineages were studied during 
3-D culturing.
Results and discussion. MSCs isolated from adult 
human bone marrow, dermal and adipose tissues after 
expansion in monolayer culture had similar phenotype 
and growth patterns as well as ability to induced multilin-
eage differentiation. After encapsulation in AMB, MSCs 
had spherical shape and during 3-D culture they stopped 
to proliferate, but possessed viability and capability to dif-
ferentiation toward adipogenic and osteogenic lineages. 
After seeding in 3-D wide-porous scaffolds, cells attached 
to porous surface, proliferated and filled pores during 
culturing. In the presence of definite inducers, MSCs 
were able to multilineage differentiation. The efficiency 
of osteogenic and adipogenic differentiation depended 
on scaffold type and composition.
Some approaches for storage, transportation and 
cryopreservation of MSC-based tissue-engineered con-
structs are presented and discussed.
Conclusions. Varying the properties of MSCs and 
scaffolds made it possible to generate different tissue 
engineered constructs that can be applied for correction 
of a wide range of tissue defects.
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Introduction. Premature ovarian failure is observed 
in 1% of women under 40 and 0.1% under 30 years; 
among those 37% cases are due to iatrogenic causes 
(mainly after cancer treatment). Problem of rehabilita-
tion after chemotherapy is more important for women, 
because chemotherapy often leads not only to hepatic 
and renal dysfunction, but to severe menopause, psycho-
emotional, sexual, disorders, cardiovascular diseases 
(A.J. Fenton et al., 2015). In recent years, cell and tissue 
therapy is considered as an alternative method of treat-
ment of iatrogenic menopausal disorders and premature 
ovarian failure. The human placenta is a promising source 
of stem cells and biologically active substances capable 
of affecting the female organism. For reasons of biosafety, 
only cryopreserved material is possible to use for clinical 
application (O.S. Prokopyuk et al., 2017).
Aim of this study was to compare different methods 
of tissue and cell therapy in the rehabilitation and recovery 
after chemotherapy in female mice.
Materials and Methods. The research was per-
formed on BALB/c mice model of ovarian insufficiency 
induced by cyclophosphamide and busulfan (G.Y. Xiao 
et al., 2014). The dynamics of ovarian, sexual function, 
morphology of liver and kidney, the general state of the 
animals was studied after application of cryopreserved 
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explants, extract, placental MSCs, adipose tissue 
MSCs obtained by the previously developed methods 
(D. Pogozhykh et al., 2015).
Results and discussion. In the chemotherapy group 
without rehabilitation, loss of weight, absence of regular 
changes in vaginal cytology, atrophy of the ovaries and 
uterus, cirrhotic changes in the liver, a sharp edema of the 
cortical and medullar layers іn the kidneys was observed. 
The most rapid and complete recovery of the reproduc-
tive system, liver and kidney was noticed using placental 
explants, MSCs or extract. Application of adipose tis-
sue MSCs led to slower recovery, but prevented critical 
changes (cirrhotic changes in the liver, kidney tubular 
necrosis). Recovery of morphology of liver and kidney, 
regular changes in vaginal cytology, sexual function, but 
not fertility was observed since follicles were lost in this 
model. Sensitivity to chemotherapy and treatment in some 
mice depended on the individual characteristics of the 
organism.
Conclusions. It was shown that the different meth-
ods of cell and tissue therapy are comparably efficient 
in the rehabilitation after chemotherapy and treatment 
of chemotherapy-induced ovarian failure. The applica-
tion of placental preparations leads to faster and more 
complete recovery of the female reproductive system.
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Introduction. Identification and characterization 
of the population of cancer stem cells (CSC) depends 
on several cellular markers, which combination is specific 
for the phenotype of CSC in the corresponding tumor. 
Several markers of CSC have already been identified 
in breast cancer (BC), but there are no universal indicators 
that could specifically identify the CSC in BC.
Aim. To determine the validation of the CSC model for 
cell surface markers such as CD44 and CD24 and their 
clinical significance.
Materials and Methods. Primary tumor samples 
of 45 patients with invasive BC without chemotherapy 
prior to surgery were examined in paraffin blocks. 
CD44 and CD24 expression was evaluated by the per-
centage of positive cells using different chromogens and 
the MultiVision detection system (Thermo Scientific, USA) 
by immunohistochemical (IHC) method. In this research 
the evaluation was determined by the following criteria: 
(−), negative — expression in < 10% of tumor cells; (+), 
positive — expression in ≥ 10% of cells. The same scoring 
system was applied for the expression of CD44+/CD24−.
Results and discussion. 62.2% of investigated 
patients were older than 50 years and most of them had 
stage II of the disease (71%) and luminal tumor subtypes 
(68.9%). We analysed the expression of CD44 and CD24, 
CD44+/CD24− for different patients by dividing them into 
two groups. The group A consists of the patients with 
unfavorable prognosis (relapses and metastases have 
occurred in the first three years after diagnosis), and the 
group B — with a favourable prognosis (the development 
of metastases after three years). Median disease-free 
survival in the group A is 19 months, in the group B — 
46 months. The difference between the overall survival 
(OS) curves in the groups A and B is statistically significant 
(p < 0.001), the risk of death was higher in the group A 
[HR 5.9; CI 2.3–15.2].
The content of CD44 cells did not differ statistically be-
tween groups A and B (p = 0.18), but there was a tendency 
for increasing in OS with the existence of CD44+ cells (p = 
0.056). The distribution of the expression of CD24 marker 
did not differ between the groups (p = 0.36) as well as the 
OS curves (p = 0.59).
Analysis of the expression of CD44+/CD24-, which 
were considered as possible CSC, revealed a paradoxical 
increase (p = 0.03) in the frequency in patients of the group 
B (40.9%) compared to the group A (8.7%). Nevertheless, 
the comparison of the clinical outcomes did not reveal 
a statistically significant difference in the survival curves 
in the groups with existence and absence of CD44+/CD24− 
expression (p = 0.08). The analysis showed the increase 
of the risk of worse clinical outcomes in the cases of ab-
sence of CD44+/CD24− expression [HR 2.8 CI 1.1–6.8].
Conclusions. As a result of our research, the analysis 
of the percentage of assumed stem cells of the BC, which 
were identified by IHC as CD44 and CD24 cells, failed 
to detect a statistically significant relation between groups 
of patients with different prognosis, and the identification 
of their expression is not enough for the characteristics 
of CSC.
The obtained data demonstrating the worst clinical 
outcome in the cases of absence of CD44+/CD24− ex-
pression apparently require further investigations and 
the validation of the IHC method with the determination 
of the cut-off line in defining of CD44 and CD24 status.
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Introduction. Transplantation of neurogenic stem 
cells is increasingly used in the treatment of a number 
of degenerative diseases of the central nervous sys-
tem. Neurogenic cells of the olfactory bulb of humans 
and mammals possess stem properties: when cultured 
in a nutrient medium with mitogens they form neuro-
spheres, and in the presence of retinoic acid they dif-
ferentiate into neurocytes and gliocytes.
Aim. To study the effect of transplantation of olfactory 
bulb cells (TOBC) on the motor activity of rats in experi-
mental spinal cord trauma.
Materials and Methods. Experimental groups of ani-
mals (white outbred male rats) included: 1) modeling 
of the left-sided half-intersection (LHI) of the spinal cord 
in the lower thoracic region (n = 24); 2) and 3) — TOBC 
in the tissue of the spinal cord below the LHI at 7 (n = 4) 
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and 13 (n = 4) weeks after injury. Cells from the rat olfac-
tory bulb were cultured in the presence of growth factors 
hEGF and hFGF for 10 days. Estimation of motor activity 
of experimental animals in comparison with control ani-
mals was taken into account according to D.M. Basso, 
M.S. Beattie and J.C. Bresnahan (BBB) scale and param-
eters of electroneuromyography (gastrocnemius of the 
posterior ipsilateral limb) with direct stimulation of the 
spinal cord above the LHI.
Results. TOBC at 7 weeks after modeling of LHI in rats 
causes an increase in the rate of the hind limbs function 
growth. After TOBC the magnitude of the maximum am-
plitude of the M-response of the muscle being studied 
was significantly lower than that in group 1 compared 
to group 2.
Conclusions. TOBC in the long-term post-traumatic 
process provides a positive functional effect against the 
background of a decrease in electrical activity in the ef-
ferent parts of the motor system of the spinal cord, which 
reflects the antispastic potential of the method.
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Human ALP is classified into four isoforms: intestinal 
(ALPI), placental (ALPP), germinal (ALPG) and tissue non-
specific (bone/kidney/liver) (TNAP). Intestinal, placental 
and germinal ALPs have higher homology between them-
selves than TNAP. The first three ALP genes are located 
on chromosome 2q34–37, in contrast the TNAP gene 
that is located on chromosome 1p36.1–34. It is referred 
that alkaline phosphatase is considered a non-specific 
tumor-related marker. However, the origin and nature 
of tumor-related alkaline phosphatase is not clear. 
We have focused on the role of ALP in chronic myeloid 
leukemia (CML) progression.
Hematopoietic stem cells (HSCs) possess the ability 
to self-renew and to differentiate to mature progeny along 
multiple different hematopoietic lineages. The function 
of HSCs depends upon the signals from surrounding cells 
found within the highly specialized microenvironment 
termed the hematopoietic stem cell niche. HSC niche was 
first conceptualized by Schofield in 1978 and was defined 
as “an entity in which the stem cell’s maturation is pre-
vented and the properties of ‘stemness’ are preserved”. 
In addition, we suggest that hematopoiesis taking place 
in the bone marrow is orchestrated by HSC niche. Under-
standing and exploiting the HSC niche is a goal of basic 
research of the hematological malignancies. Osteocytes 
in bone marrow niche are essential for granulocyte 
colony-stimulating factor (G-CSF), which is the major 
cytokine regulator of G-CSF-induced hematopoietic 
stem/progenitor mobilization (N. Asadaet et al., 2011). 
Myelopoiesis is regulated by HSC niche’s osteoblast/
osteocytes signaling through HSCs granulocyte colony-
stimulate signaling (K. Fulzele et al., 2012). ALP activity 
was detected widely in osteoblasts of HSC niche in the 
bone marrow, about 20% of bone marrow cells expressed 
ALP activity (D. Miao, A. Scutt, 2002). Taken together, 
ALP is secreted by bone marrow HSC niche osteoblasts 
and has role in regulation of myelopoiesis through G-
CSF signaling. As a result, the niche-associated ALP 
gene expression was absent in blood cells of healthy 
persons as we have shown. In addition to this, normal 
HSC is marked by G-CSFR (granulocyte colony-stimulate 
factor receptor), while leukemic hematopoietic cells lose 
this marker. Unexpectedly, we have observed the aberrant 
placental ALP gene expression in the peripheral blood 
cells in CML patients (n = 8). The aberrant placental ALP 
expression was investigated by real-time RT-PCR with 
consequent amplicone-DNA sequencing analysis. We first 
found the phenomenon of the phenotypic molecular 
switching from normal TNAP to ALPP in the hematopoi-
etic niche induction during leukemogenesis. We have 
proposed that aberrant ALPP highlights the leukemic 
stem cell niche feature in CML progression. Moreover, 
we have firstly elucidated the epigenetic reverse regula-
tion of aberrant ALPP gene expression in CML patients 
by histone deacetylase inhibitor (HDACi) sodium butyrate 
in culture of blood cells. In addition, the targeted increase 
of G-CSFR mRNA expression has been shown. In con-
clusion, we have suggested that aberrant placental ALP 
is the leukemogenic-derived alkaline phosphatase that 
drives HSC plasticity in leukemic stem cell survival. Based 
on the date obtained, we discuss targeting potentially 
capable of epigenetic reversion of the leukemic stem 
cell phenotype.
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Introduction. The development and functioning 
of a multicellular organism is impossible without regulation 
of cell division and cell differentiation processes. It is just 
their mutual regulation, on the one hand, causes step-by-
step narrowing of cell potentiality during embryogenesis 
and, on the other hand, maintains the renewal of cellular 
composition and spatial arrangement of tissues during the 
reparation processes in adult organism. Disturbances in the 
above regulation are then considered to be responsible for 
a number of pathological processes in organism including 
carcinogenesis.
At present there is no consensus on the mechanisms 
of the regulation of cell division/differentiation processes. 
However, none of the existing concepts are capable 
of giving a complete solution of the regulation problem 
till they do not touch the question of interdependence 
between the proliferation and differentiation processes 
in the heterogeneous populations of normal stem cells.
Aim. The purpose of the present study is to show 
that in the heterogeneous population of stem cells the 
mechanism of proliferation — differentiation processes 
based on the inhibition of the proliferating stem cells 
by differentiation factors (special messengers synthe-
sized by the differentiated cells) can result in the selec-
tion of actively proliferating cells that are insensitive 
to the action of differentiation factors.
Methods. The problem of regulation of the prolifera-
tion — differentiation processes is analyzed in the frame-
work of the mathematical model of unipotential stem cell 
clone dynamics, assuming two alternative scenarios 
of an every new-born cell development, which in the long 
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run define correspondingly the proliferating or differenti-
ated cell status. The scenario choice is then supposed 
to be a random event influenced by both the inherent 
mitotic activity of stem cell and the differentiation factors.
Results and discussion. Taking into account the 
heterogeneity of stem cells it was shown that such 
mechanism of the regulation of proliferation — differen-
tiation processes can result in the selection of actively 
proliferating and cells that are insensitive to the action 
of differentiation factors (that is to say, the cells with 
cancer phenotype). We called this phenomenon an au-
toselection. In the framework of the model, the low level 
of the intraclonal heterogeneity of the mitotic activity 
index of stem cells is necessary but not sufficient for the 
emergence of the cells with cancer phenotype. Another 
important condition, which is necessary for the appear-
ance of such cells in the clone, is the increase of the 
interclonal heterogeneity of stem cells.
Conclusions. The stem cells with cancer phenotype 
appears through the series of the permanent nonmuta-
tional changes by autoselection mechanism retaining 
for the division and generation of the progeny only that 
actively proliferating cells which are less sensitive with 
respect to the action of the differentiation factors. The 
progression of normal stem cells towards the appear-
ance and increase of the number of the cells with cancer 
phenotype can be considered as a possible mechanism 
of carcinogenesis.
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Introduction. Cancer stem cells (CSCs) today are the 
subject of intensive research in experimental and clinical 
oncology. Their presence in the tumor area is associ-
ated with aggressive course and resistance to therapy. 
Currently, the search and development of new therapy 
approaches for the treatment of malignant tumors with 
CSCs is conducted worldwide. Experimental studies 
have shown that higher antitumor activity have natural 
antioxidant proteins, including lactoferrin (LF), compared 
to synthetic analogs. LF is characterized by a unique set 
of biological properties of a different nature. At the same 
time, the peculiarities of the LF influence on breast cancer 
(BC) cells with the CSC phenotype have not been finally 
determined.
Aim. To investigate the cytotoxic and genotoxic ef-
fects of exogenous LF on hormone receptor-positive and 
receptor-negative human BC lines with CSC phenotype.
Materials and Methods. The hormone receptor-
positive (MCF-7) and receptor-negative (MDA-MB-231) 
human BC cell lines, positive for CSC markers, were 
cultured with an exogenous LF at a dose corresponding 
to IC30 (10 µg/ml for receptor-positive cells, 5 µg/ml for 
receptor-negative cells). Flow cytometry, immunocyto-
chemical, and statistical methods were used.
Results. Cultivation with exogenous LF resulted 
in reducing the number of cells with the CSC-like phe-
notype both in hormone-receptor-positive and receptor-
negative BC cell lines. This is evidenced by a reduction 
in the number of cells positive for CD44 expression, 
in MCF-7 by 55% and the 4.5-fold increase of CD24 ex-
pression in MDA-MB-231cells. We have found that after 
incubation with LF, MCF-7 and MDA-MB-231 cells dem-
onstrated increased levels of reactive oxygen species 
(2.0–1.7-fold, p < 0.05), inducible NO generation rate 
of NO-synthase (1.6–1.9-fold, p < 0.05) and the level of 
“free iron” (1.7–2.3-fold, p < 0.05). In addition, the effects 
of LF were more pronounced in MDA-MB-231 receptor-
negative cell line. These changes resulted in the increased 
expression of proapoptotic protein Bax (by 10–16%, 
p < 0.05), reduced expression of the antiapoptotic protein 
Bcl-2 (16–21%, p < 0.05) and lowering level of unoxidized 
mitochondrial phospholipid cardiolipin (by 1.6–2.4 times, 
p < 0.05). This, in turn, caused an increase in the number 
of cells killed by apoptosis (14–29.1%, p < 0.05). Cy-
totoxic effects of LF were accompanied by an increase 
in the percentage of DNA in “comet tail” (by 1.8–4 times, 
p < 0.05) and the blockage of cell cycle at G2/M phase, 
especially in receptor-negative cell line.
Conclusions. The obtained data indicate that ex-
ogenous LF shifts pro-/antioxidant balance of hormone 
in receptor-positive and receptor-negative human 
BC cells with the CSC phenotype by increasing the 
level of reactive oxygen species, “free iron” and the rate 
of NO generation. These disruptions lead to the blockage 
of the cell cycle in the G2/M phase and the death of malig-
nant cells by apoptosis. Further study of the mechanisms 
of LF influence will justify the need for its use to modify 
the phenotype of cells positive for the expression of CSC 
markers.
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Introduction. Human dental pulp is a rich source 
of postnatal mesenchymal stem cells which can self-
renew and undergo differentiation into multiple lineages. 
FGF8 is a paracrine-acting FGF family ligand, expressed 
during the earliest stages of tooth site determination and 
indispensable for mediating epithelial-to-mesenchymal 
interactions initiating odontogenic differentiation during 
embryogenesis.
Aim. To examine differential protein analysis in adult hu-
man dental pulp in response to short- and long- term treat-
ment with FGF8 in order to assess its value as a the rapeutic 
agent for the purposes of pulp regeneration.
Materials and Methods. Intact human premolar 
teeth were obtained from healthy patients between the 
ages of 18 and 40 following the acquisition of written 
consent. Dental pulps were exposed using diamond burs 
and extracted using sterile barbed broaches. Tissue ex-
plants were enzymatically digested with collagenase type 
I (3 mg/ml) and disease (4 mg/ml) for 1 h at 37 °C and 
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cultured in DMEM with added 20% heat-inactivated fetal 
bovine serum (FBS). Hetero genous cell culture was main-
tained at standard culture conditions with supplemented 
10% FBS. Upon reaching the third passage, samples run 
in triplicates were subjected to short- (24 h) and long-term 
(10 days) treatment with 10 ng/ml human recombinant 
FGF8. 2D DIGE analysis was conducted using 24-cm strips 
in the narrow 4–7 pH range for the first dimension and 
SDS-PAGE (8–16%) for the second. Protein spots were 
subsequently identified by MALDI-TOF/TOF-MS.
Results and discussion. 20 protein spots identified 
by MALDI-TOF/TOF-MS with high confidence were found 
to be differentially expressed among treatment groups 
as compared to untreated controls. These belonged 
to clusters of gluconeogenesis (tri osephosphate isomer-
ase), cellular structure and motility, inflammation, protein 
biosynthesis, trafficking and degradation, cell cycle and 
DNA repair, osteogenic differentiation, cytokinesis and 
vesicle trafficking.
Conclusions. In summary, the proteomic ap-
proach has yielded novel information about the effect 
of FGF8 on cells of adult dental pulp with identified proteins 
being linked to regulation of actin cytoskeletal rearrange-
ments, migration, osteogenic differentiation, neuronal cell 
function, consistent with what has been reported about the 
role of FGF8 in the context of embryonic tooth development 
and the neural crest origin of dental pulp cells. FGF8 is likely 
to be able to instigate pulp cell migration and odontogenic 
differentiation in response to pulp injury in an appropriate 
model organism, however further studies need to be con-
ducted to evaluate its therapeutic potential.
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Introduction. Neural crest is a transient structure 
during embryonic development of vertebrates which 
gives rise to peripheral nervous system; melanocytes; 
cartilage, bone and connective tissue in head; some 
endocrine cells, etc. Several tissues and organs of adult 
mammals contain adult neural crest-derived multipotent 
stem cells (NC-MSCs) and they have great potential 
to use in regenerative medicine.
Aim. To obtain the NC-MSCs from human hair fol-
licle, characterize their morphological and functional 
properties; based on our positive results in animal models 
to conduct pilot human studies for treatment of spinal 
cord injuries (SCI), degeneration of intervertebral disks 
(IVD) and calvarial bone defects.
Materials and Methods. All procedures were per-
formed with the voluntary informed consent of patients and 
in accordance with the current legislation of Ukraine. NC-
MSCs were obtained from hair follicle by explant method 
and expanded by our original protocol. Cultured NC-MSCs 
were characterized by qPCR, immunocytochemistry, flow 
cytometry, cytogenetic and functional assays. Cytokines 
and growth factors produced by NC-MSCs were determined 
by ELISA and Bio-Rad multiplex assay. Patients subjected 
to non-effective standard drug therapies, surgery approaches 
or neuro-rehabilitation have received the cell therapy treat-
ment or transplantation tissue-engineered (TE) bone equiva-
lent. Three patients with contusion SCI received single com-
bined paravertebral and intrathecal injections (20•106 cells 
per injection/patient). Ten patients with IVD degeneration, 
herniation and pain syndrome received only paravertebral 
cell injection (10•106 cells per patient). Three patients with 
critical sized calvarial bone defects had the transplantation 
of TE bone equivalent. Minimal follow-up period was 1 year.
Results and discussion. Adult NC-MSCs were 
successfully isolated and expanded from all patients. 
NC-MSCs have stable karyotype, Sox2+ Sox10+ Nestin+ 
CD73+ CD90+ CD105+ CD140a+ CD140b+ CD146+ CD166+ 
CD271+ CD349+ CD34- CD45- CD56- HLA-DR- phenotype 
and were able to self-renewal and directed differentia-
tion in vitro into neurons, Schwann cells, melanocytes, 
osteoblasts, chondrocytes and adipocytes. NC-MSCs 
secreted the following proteins: NGF, BDNF, NT-3, NT-
4/5, IL-1ra, IL-10, bFGF, VEGF, and GM-CSF. Two patients 
with lumbar SCI caused by shrapnel improved from ASIA 
C to ASIA D after cell therapy. One patient with thoracic 
SCI caused by bullet improved from ASIA B to ASIA C af-
ter treatment. Treated patients showed the restoration 
of sensitivity as well as the emergence of active move-
ments and strength grown in paretic limbs. Ten patients 
with IVD degeneration showed a significant improvement 
in pain syndrome and reduction in size of a protrusion/
extrusion. In three patients, the calvarial bone defects 
were successfully restored with TE bone equivalent.
Conclusion. NC-MSCs can be efficiently obtained 
and expanded from adult human hair follicle. Our pre-
liminary results have shown significant therapeutic and 
regenerative potential of this cell type.
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Introduction. Combat-related bone defects are 
manifested in 10–12% of casualties, and 30% of these 
defects are complicated with osteomyelitis. The greatest 
difficulties arise in the treatment of diaphyseal bone de-
fects more than 5 cm and metaepiphyseal defects that ex-
ceed 15–20 cm3. Treatment of critical sized bone defects 
is an actual clinical challenge. The “gold standard” in this 
case is autologous bone grafting. But disadvantage of this 
method is associated with limited donor bone resources.
Aim. Based on our preliminary positive clinical results 
with use of cultured bone marrow-derived multipotent 
mesenchymal stem/stromal cells (BM-MSCs) in trau-
Experimental Oncology 39, 234–256, 2017 (September) 255
matology, our aim was to develop 3D tissue-engineered 
bone equivalent (3D-TEBE) transplantation technology 
for restoration of critical sized bone defects.
Materials and Methods. To fabricate 3D-TEBE 
we used devitalized allogeneic bone (blocks and chips) 
seeded with cultured autologous cells: BM-MSCs in mix 
with periosteum progenitor cells (PPCs) and endothelial 
progenitor cells (EPCs). Quality/identity of cell cultures was 
assured by flow cytometry (cell phenotype), cytogenetic 
analysis (GTG-banding), donor and cell cultures infection 
screening (IFA, PCR), functional analysis (cell kinetics, CFU 
analysis, multilineage differentiation assay, cell senescence 
assay). 3D-TEBE transplantation was performed in 47 com-
bat-injured with 49 bone defects. New bone formation 
was assessed by the radiographic examination. Treatment 
was based on local clinical protocol approved by Ministry 
of Health of Ukraine.
Results and discussion. Patients were included 
in a treatment program 8–19 months after injury, provid-
ed the ineffectiveness of conventional surgery methods. 
All cell cultures had a normal karyotype and phenotype, 
differentiation potential and functional properties, 30% 
CFU frequency and hadn’t any signs of cell senescence. 
FDA/PI staining, MTT-assay and histological analysis 
of 3D-TEBE samples showed their regular seeding with 
viable cells. Histological analysis of 3D-TEBE biopsies 
3 months after transplantation taken within adoptive 
resection surgery showed immature bone tissue forma-
tion. Restoration of all bone defects was observed after 
5–6 months (by radiographic examination).
Conclusions. The developed biotechnology of 3D-
TEBE transplantation allows restoring the bone integrity, 
forming new bone tissue in a site of bone defect, and 
significantly reducing the rehabilitation period of a patient.
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Introduction. Due to the active development of cellular 
technologies, the study of the genetic stability of human 
stem cells (SCs) is receiving increasing attention. Since the 
amount of SCs isolated from the body is too small to be used 
for medicinal purposes, they should be expanded in culture. 
In the course of culturing, de novo-induced chromosomal 
abnormalities are possible, giving rise to abnormal cell lines. 
Accumulation of such abnormalities can lead to malignant 
transformation of cells.
Aim. To assess the chromosomal variability of mesen-
chymal stem cells (MSCs), depending on the source of cell 
production and the duration of their cultivation.
Materials and Methods. MSCs were isolated from 
bone marrow and adipose tissue. Their genetic stability was 
evaluated by the method of karyotyping using specialized 
software. G-staining in metaphase plates was provided for 
cytogenetic analysis.
Results. We conducted a cytogenetic analysis 
of a number of MSC cultures originating from bone mar-
row and adipose tissue starting from the 2nd and ending 
with the 10th passage. In all samples under study, neither 
metaphase plates with an altered chromosome number 
nor structural changes in the chromosomes were detected 
upon cell culture.
Conclusions. The results of our studies showed that the 
methods used for MSC isolation, as well as the conditions 
for their cultivation, preserve the normal karyotype of the 
cells at the early passages.
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Introduction. The clinical significance of the molecular 
heterogeneity of prostate cancer (PC) is actively discussed 
in recent publications due to the important role of cancer 
stem cells (CSC) in the disease course. The presence 
of these cells is a determining factor for the growth and 
progression of the tumor, its metastatic activity, and also 
sensitivity to therapy. In this regard, the study of the mo-
lecular profile of cells with the CSC phenotype is an urgent 
issue, the solution of which will help to deepen knowledge 
about the biology of tumor growth.
Aim. To investigate the features of the molecular pro-
file of PC cell lines, depending on the expression of CSC 
markers (СD24 and СD44).
Materials and Methods. The study was conducted 
on human PC cell lines (DU-145 and LNCaP). Expression 
of CSC markers (CD24 and CD44), steroid hormones re-
ceptors (testosterone (AR), estrogen α (ERα), progesterone 
(PR) and epidermal growth factor — (HER2/neu)), E-cad-
herin and Kі-67 was determined by the immunocytochemi-
cal method. The evaluation of the results was performed 
using optical microscopy by H-Score method. The marker 
expression levels were considered to be high at the values 
from 201 to 300 points of the H-Score, average — from 
101 to 200 points of the H-Score, and low at the range from 
0 to 100 points of the H-Score. The invasive activity of the 
cells was examined using a standard invasive test accord-
ing to the manufacturer’s instructions (BD Biociences). 
STATISTICA 6.0 software was used to process the results.
Results. The study of CD24 and CD44 expression 
demonstrated that the PC cell lines differ in expression 
of CSC markers. DU-145 cells were positive for the CSC 
phenotype (CD44+/CD24–), while LNCaP cells had low 
levels of CD44 (65 ± 12.3 points of the H-Score) and did 
not express CD24. We established that DU-145 cells with 
CSC phenotype exhibit a high level of testosterone recep-
tor (250 ± 14.6 points of H-Score), low level of HER2/neu 
(60.3 ± 14.6 points of H-Score), and have lack of ER, PR, 
and E-cadherin expression.
In the cells of LNCaP line, negative for the CSC pheno-
type, we observed a high level of testosterone expression 
(272.6 ± 10.3 points of the H-Score), the average PR ex-
pression (145.7 ± 11.0 points of the H-Score), the absence 
of HER2/neu, and the average level of E-cadherin (187.7 ± 
16.0 points of the H-Score).
Cells with the CD44+/CD24– phenotype of DU-145 cell 
line were characterized by a high proliferative (Ki-67 le-
vels considered to be 265.0 ± 20.5 points of the H-Score) 
and invasive activity (0.37/1000 cells) compared to the 
LNCaP cells (Ki-67 level amounted 174.0 ± 24.6 points 
for H-Score, the invasive activity was 0.076/1000 cells, 
respectively).
Conclusions. The association of the presence of CSC 
markers with a high proliferative and invasive activity 
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and a decrease in the adhesion properties of PC cells 
has been established. The findings point to the need for 
a more in-depth study of the role of CSC in the biology 
of cell growth.
ENDOMETRIAL STROMAL CELLS: 
ISOLATION, EXPANSION, MORPHOLOGICAL 
AND FUNCTIONAL PROPERTIES
A.v. Zlatska1, 2, A.e. Rodnichenko1, 2, О.S.Gubar2, 3, 
d.О. Zubov1, 2, S.n. novikova1, R.G. vasyliev1, 2
1State Institute of Genetic and Regenerative Medicine, 
National Academy of Medical Sciences of Ukraine, 
Kyiv, Ukraine
2Biotechnology Laboratory ilaya Regeneration, Kyiv, 
Ukraine
3Institute of Molecular Biology and Genetics,  
National Academy of Sciences of Ukraine, Kyiv, Ukraine
alenazlatcka@gmail.com
Introduction. The endometrium is a unique struc-
ture that is able to complete self-renewal over a month 
cycle, and undergoes these changes over 400 times 
during woman reproductive age. A significant regenera-
tive potential is due to the presence of stem cells in the 
endometrium, such as mesenchymal, epithelial and 
endothelial progenitor cells. That is why endometrium 
is a promising object for MSCs isolation and in vitro 
short-term expansion for their further exploration and use 
in assisted reproductive technologies, reproductology 
and regenerative medicine.
Aim. To study the biological properties of human 
endometrial stromal cells in vitro.
Materials and Methods. The endometrium samples 
(n = 10) were obtained by biopsy at the first phase of the 
menstrual cycle from women with endometrial hypopla-
sia. In all cases, a voluntary written informed consent was 
obtained from the patients. Endometrial fragments were 
dissociated by enzymatic treatment for 1 h in 0.05% col-
lagenase IA and 0.05% pronase and 2% FBS. The cells 
were cultured in DMEM:F12 supplemented with 10% FBS, 
2 мМ L-glutamine and 1 ng/ml FGF-2 in a multi-gas incu-
bator at 5% CO2 and 5% O2. For the phenotype determi-
nation, the ability to directed adipogenic, osteogenic and 
chondrogenic differentiation assays, CFU-test, karyotype 
stability, the P3-cells have been used. The cell secretome 
was assessed by BioRad Multiplex immunoassay kit.
Results and discussion. Primary population of en-
dometrial cells was heterogeneous and contained cells 
with fibroblast-like and epithelial-like morphology, but 
at P3 the majority of cell population had fibroblast-like 
morphology. The cells possessed MSCs typical pheno-
type CD90+CD105+CD73+CD34-CD45-HLA-DR- assessed 
by flow cytometry. Positive expression of CD146+CD166
+CD49f+CD140a+CD140b+nestin+ was determined. Cell 
doubling time is 29.6 ± 1.3 h. They were capable of di-
rect osteogenic and adipogenic differentiation. The cells 
showed 35.7% colony forming efficiency and a tendency 
to 3D spheroid formation. The GTG-banding assay con-
firmed the stability of eMSC karyotype during long-term 
culturing (up to P8). After 48 h incubation period in serum-
free medium eMSC secreted anti-inflammatory IL-1ra 
(74.6 ± 9.5 pg/ml), as well as IL-6 (29.8 ± 8.3 pg/ml), 
IL-8 (138.5 ± 33.3 pg/ml) and IFNγ (55.9 ± 3.8 pg/ml), 
angiogenic factors VEGF (92.2 ± 19.8 pg/ml), GM-CSF 
(133.2 ± 5.1 pg/ml) and FGF-2 (17.8 ± 4.3 pg/ml), che-
mokines IP-10 (39.9 ± 3.3 pg/ml) and MCP-1 (41.1 ± 
6.7 pg/ml).
Conclusion. Thus, obtained endometrial stromal 
cells meet minimal ISCT criteria for MSCs, such as adher-
ence to plastic in standard culture conditions, expression 
of typical phenotype markers and ability for the directed 
differentiation in vitro. eMSCs are stable during long-
term culturing. They also produce a range of cytokines, 
chemokines and growth factors. Proliferative potential, 
karyotype stability and secretome profile make them 
a perspective object for the use in the regenerative 
medicine.
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